Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC	Top correlated gene
ENSG00000117242	PINK1-AS	-1.31376175647539	8.82609285126616e-6	M1_vs_M2	HSALNG0001460	intronic_antisense	Not conserved	NA	-	DDOST	LRCH3
ENSG00000125462	MIR9-1HG	5.57808525803185	2.51960715857463e-16	M1_vs_M2	HSALNG0007588	sense	Not conserved	NA	NA	MEF2D	COL1A1
ENSG00000162888	C1orf147	2.65217635780778	1.36208119826184e-10	M1_vs_M2	NA	NA	NA	NA	NA	EIF2D	KPNA2
ENSG00000166770	ZNF667-AS1	-1.24999980058336	0.0011212090130551	M1_vs_M2	HSALNG0127764	anti_sense	Not conserved	hsa-miR-6895-5p	Alkaline phosphatase measurement; Low density lipoprotein cholesterol measurement,-	ZNF471	CELF3
ENSG00000167920	KRT10-AS1	-1.07852127217522	0.00236265890139494	M1_vs_M2	HSALNG0116399	anti_sense	Q75	hsa-miR-3960	Leukocyte count,-	KRTAP4-7	GTF3C1
ENSG00000171889	MIR31HG	-2.54309920130895	0.00103770208083161	M1_vs_M2	HSALNG0070362	anti_sense,sense	Q50	hsa-miR-4483,hsa-miR-6089,hsa-miR-7151-5p	Aging,High density lipoprotein cholesterol measurement,Coagulation factor v measurement,Susceptibility to shingles measurement,Thyroid preparation use measurement,Hypothyroidism,Autoimmune disease; Hypothyroidism; Thyroid preparation use measurement,Amblyopia,Macula measurement,Autoimmune thyroid disease,-	IFNE	CASP1P2
ENSG00000172965	MIR4435-2HG	-1.22213382474227	2.16276533033761e-11	M1_vs_M2	HSALNG0017878	integenic	Q50	NA	NA	ANAPC1	ARL6IP1P2
ENSG00000174370	KCNJ5-AS1	-2.41448922156118	1.27219817122372e-192	M1_vs_M2	NA	NA	NA	NA	NA	TP53AIP1	HOMER3
ENSG00000178803	ADORA2A-AS1	7.83531529802649	2.60623938865319e-14	M1_vs_M2	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1	C15orf48
ENSG00000180066	LINC02870	-1.28143854668461	0.0146357370149824	M1_vs_M2	HSALNG0081790	integenic	Q50	hsa-miR-1227-5p,hsa-miR-4485-5p,hsa-miR-4514,hsa-miR-4763-3p,hsa-miR-5001-3p,hsa-miR-6813-5p	-	PWWP2B	WDR81
ENSG00000181577	LINC03040	2.79140423506312	2.68844734585098e-9	M1_vs_M2	NA	NA	NA	NA	NA	TMEM63B	CD2
ENSG00000182376	NA	-2.87039477902824	0.0109559786273883	M1_vs_M2	NA	NA	NA	NA	NA	CTU2	KRT3
ENSG00000183250	LINC01547	1.26437924570838	6.672800427406091e-9	M1_vs_M2	HSALNG0133586	integenic	Not conserved	hsa-miR-1268b,hsa-miR-1273h-5p	Heel bone mineral density	ITGB2	LY9
ENSG00000185168	LINC00482	-2.83168983452719	0.00166942180812681	M1_vs_M2	HSALNG0145393	integenic	Not conserved	hsa-miR-6852-5p	-	SLC38A10	ENSG00000243225
ENSG00000185433	LINC00158	6.48051518788383	1.06021696495883e-29	M1_vs_M2	HSALNG0132374	integenic	Not conserved	NA	NA	MRPL39	ABTB2
ENSG00000186235	LINC02610	-1.46347504130537	4.12044373131607e-5	M1_vs_M2	HSALNG0023418	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-4685-3p,hsa-miR-6753-5p,hsa-miR-6784-5p,hsa-miR-1273h-5p,hsa-miR-7846-3p,hsa-miR-8072	Chronotype measurement	HES6	ZC3HAV1L
ENSG00000188825	LINC00910	-1.16199761339491	0.00153854383364425	M1_vs_M2	HSALNG0116632	integenic	Not conserved	NA	-	CCDC200	ACSS2
ENSG00000189238	LINC00943	1.92568585879654	0.00496381033049781	M1_vs_M2	HSALNG0094963	integenic	Q50	hsa-miR-619-5p,hsa-miR-936,hsa-miR-4725-3p	NA	TMEM132B	ACSS2
ENSG00000197180	ATP6AP1-DT	-1.26814409003245	1.64101205033998e-17	M1_vs_M2	HSALNG0140852	integenic	Q75	hsa-miR-619-5p,hsa-miR-4297,hsa-miR-4279	NA	DNASE1L1	VPS26C
ENSG00000197536	IRF1-AS1	3.85180148035554	6.76958577603668e-102	M1_vs_M2	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA	GP1BA
ENSG00000197989	SNHG12	-1.10825459372798	3.37057546372825e-32	M1_vs_M2	HSALNG0002075	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-324-5p,hsa-miR-3178,hsa-miR-4466,hsa-miR-6089,hsa-miR-6890-3p	-	TAF12	TP53I11
ENSG00000203446	SUGCT-AS1	1.06463790217915	3.0835390174086903e-15	M1_vs_M2	HSALNG0057426	anti_sense	Q90	hsa-miR-6089,hsa-miR-6824-3p	-	MPLKIP	TOMM34
ENSG00000203497	PDCD4-AS1	-1.06825755107374	0.0140682442478829	M1_vs_M2	HSALNG0080613	anti_sense	Q50	hsa-miR-6089	Aspartate aminotransferase measurement,-	BBIP1	SRSF8
ENSG00000203709	MIR29B2CHG	1.82980974910929	2.59158185508506e-67	M1_vs_M2	HSALNG0010132	integenic	Q50	NA	Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Reaction time measurement,Pulse pressure measurement,Red blood cell distribution width	CD34	SPECC1
ENSG00000204044	SLC12A5-AS1	1.09928769504468	1.82913521151755e-6	M1_vs_M2	HSALNG0130456	anti_sense	Q75	hsa-miR-4258	Blood protein measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement; Apolipoprotein b measurement,-	NCOA5	SLC26A6
ENSG00000204261	PSMB8-AS1	1.10778097775974	1.19633873448096e-4	M1_vs_M2	HSALNG0049455	anti_sense,sense	Q75	NA	Systemic lupus erythematosus,Iga glomerulonephritis,Kidney disease,-,Platelet-to-lymphocyte ratio,Autoimmune disease	PSMB9	FAM169A
ENSG00000204832	ST8SIA6-AS1	-5.51885556426391	2.08785783191055e-13	M1_vs_M2	HSALNG0076446	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6764-5p	Sleep apnea measurement,Urinary albumin to creatinine ratio; Moderate albuminuria,Blood protein measurement,Aspartate aminotransferase measurement,-	VIM	FGL2
ENSG00000204971	NA	-2.90842336325207	6.78237603575257e-25	M1_vs_M2	HSALNG0085534	integenic	Not conserved	hsa-miR-412-3p,hsa-miR-6769b-5p	NA	PHOX2A	BICDL1
ENSG00000205057	CLLU1-AS1	2.87588466818009	4.18992689745036e-26	M1_vs_M2	NA	NA	NA	NA	NA	BTG1	BTG2
ENSG00000205414	NA	-3.5394035498	2.59651390408284e-25	M1_vs_M2	HSALNG0144931	anti_sense	Q50	NA	NA	SNX20	DENND2D
ENSG00000205444	KU-MEL-3	6.55246512037453	7.34005131605104e-6	M1_vs_M2	HSALNG0047755	integenic	Not conserved	hsa-miR-3619-5p	Balding measurement,-	CDYL	BDNF
ENSG00000205611	LINC01597	5.04555729874157	0.0274182660589671	M1_vs_M2	HSALNG0129452	integenic	Not conserved	hsa-miR-4433a-3p	-	DEFB116	SZRD1
ENSG00000205837	LINC00487	5.68128961789932	2.64603536824766e-17	M1_vs_M2	HSALNG0012718	integenic	Q50	hsa-miR-4430	NA	CMPK2	TOR1B
ENSG00000205885	C1RL-AS1	4.16550682735499	8.623323084698501e-52	M1_vs_M2	HSALNG0088972	anti_sense	Q50	hsa-miR-4418,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6165,hsa-miR-8485	Neuritic plaque measurement,Platelet count,Platelet crit,-	CLSTN3	WNT5A
ENSG00000206337	HCP5	1.3269247448056	5.791371414803979e-69	M1_vs_M2	HSALNG0049264	sense	Not conserved	hsa-miR-4257,hsa-miR-4492,hsa-miR-6769b-5p	Trichloroethylene-induced hypersensitivity,Hiv-1 infection,Female reproductive system disease,Blood protein measurement,Heel bone mineral density,Systemic lupus erythematosus,Mhc class i polypeptide-related sequence a measurement,Uveitis,Reticulocyte measurement,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Cervical carcinoma,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Chronic hepatitis c virus infection,Psoriatic arthritis,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Bmi-adjusted hip circumference,Body weight,Neutrophil percentage of leukocytes,Response to antineoplastic agent,Beta-2 microglobulin measurement,Non-melanoma skin carcinoma,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Neutrophil count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Iritis,17-hydroxyprogesterone measurement,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Autism spectrum disorder,Mean platelet volume,Platelet count,Age at diagnosis,Eosinophil count,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Lung carcinoma,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Granulocyte percentage of myeloid white cells,Susceptibility to mononucleosis measurement,Platelet component distribution width,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Platelet-to-lymphocyte ratio,Aging,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Parental longevity,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Eosinophil percentage of leukocytes,Susceptibility to childhood ear infection measurement,Body height,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Response to drug; Drug-induced agranulocytosis,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Eczema; Allergic rhinitis,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Susceptibility to pneumonia measurement,Human papilloma virus infection; Oropharynx cancer,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio	MICB	OGFR
ENSG00000206344	HCG27	1.75330516767172	0.00320377528630869	M1_vs_M2	HSALNG0049246	integenic	Not conserved	hsa-miR-4640-3p,hsa-miR-6769b-5p	Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Bmi-adjusted waist-hip ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Lymphocyte count,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Von willebrand factor measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,High density lipoprotein cholesterol measurement,Lung carcinoma,Response to thioamide; Drug-induced agranulocytosis,Handedness,Lupus nephritis; Blood protein measurement,-	TCF19	RFXANK
ENSG00000214401	KANSL1-AS1	-1.02155007943839	5.49693615946887e-8	M1_vs_M2	HSALNG0116913	anti_sense	Q75	hsa-miR-4665-3p,hsa-miR-9899	-	LRRC37A	ARHGAP12
ENSG00000214870	LINC02981	-1.74207057338998	1.13096683878769e-8	M1_vs_M2	HSALNG0056819	integenic	Not conserved	NA	NA	SNX10	VAT1L
ENSG00000214922	HLA-F-AS1	1.35426129955621	1.99396010042832e-5	M1_vs_M2	HSALNG0049088	anti_sense	Not conserved	hsa-miR-575,hsa-miR-8485	Age at menopause,Cytokine measurement,Psoriatic arthritis,Bmi-adjusted waist-hip ratio; Hodgkins lymphoma, mixed cellularity,Lung carcinoma,Bmi-adjusted hip circumference,Self reported educational attainment; Cognitive function measurement,Urate measurement,-	ZFP57	ENSG00000254317
ENSG00000215244	LINC02649	1.06902540843984	0.0198155117399642	M1_vs_M2	HSALNG0142500	integenic	Not conserved	NA	Rheumatoid arthritis,Thyroid preparation use measurement	PFKFB3	NPR1
ENSG00000215458	AATBC	-2.15224281053322	2.81518131145182e-31	M1_vs_M2	HSALNG0133454	anti_sense	Not conserved	hsa-miR-6089	-	CSTB	PAQR4
ENSG00000216863	LY86-AS1	-2.58689672308022	8.50500120277013e-51	M1_vs_M2	HSALNG0047825	integenic	Not conserved	NA	NA	F13A1	ALDH3A1
ENSG00000219665	ZNF433-AS1	-2.16142453364639	2.30636030574998e-15	M1_vs_M2	HSALNG0124080	anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-4290,hsa-miR-4488,hsa-miR-6735-5p	Corneal endothelial cell measurement,Heel bone mineral density,-	NA	FHOD1
ENSG00000222017	NA	5.04555454941752	0.0216464292629656	M1_vs_M2	HSALNG0021397	anti_sense,sense	Not conserved	hsa-miR-4268	Monocyte count,Red blood cell distribution width,Circadian rhythm,Chronotype measurement,Rheumatoid arthritis,Platelet count,Brain aneurysm,Body mass index,-	MARS2	LGALS14
ENSG00000222032	NA	-5.7485341024734	0.00433050097902438	M1_vs_M2	HSALNG0023343	integenic	Q75	hsa-miR-6865-5p	Body height,-	COL6A3	ADAMTS8
ENSG00000222042	NA	6.2219701279296	2.60519309964585e-4	M1_vs_M2	HSALNG0132366	integenic	Not conserved	NA	NA	MRPL39	RN7SKP26
ENSG00000223704	LINC01422	-1.41590061158346	0.0121111520434219	M1_vs_M2	HSALNG0134677	integenic	Not conserved	hsa-miR-7108-3p	-	CRYBA4	ENSG00000289507
ENSG00000223749	MIR503HG	1.95094960495837	9.14594410706145e-6	M1_vs_M2	HSALNG0140233	integenic	Q90	hsa-miR-4292	Body height; Testosterone measurement,Testosterone measurement	PLAC1	SEMA3A
ENSG00000223901	NA	2.55259975288511	2.14268969045727e-11	M1_vs_M2	HSALNG0133720	anti_sense	Q50	NA	-	YBEY	TNFAIP8
ENSG00000223949	ROR1-AS1	-2.41416101221392	7.66094311427804e-93	M1_vs_M2	HSALNG0004144	anti_sense	Q90	NA	Intelligence,Blood protein measurement,-	ITGB3BP	PTPRO
ENSG00000223969	NA	1.32686200255523	0.00125852020462459	M1_vs_M2	HSALNG0059467	anti_sense	Q75	NA	-	FAM237B	NAA20
ENSG00000224116	INHBA-AS1	3.4293034466787	0.00290728509121599	M1_vs_M2	HSALNG0057482	integenic	Not conserved	hsa-miR-6124	NA	SUGCT	SLC39A13
ENSG00000224186	PITX1-AS1	-1.38680195085738	6.82470470920645e-5	M1_vs_M2	HSALNG0045024	integenic	Not conserved	NA	NA	CATSPER3	AATF
ENSG00000224307	LINC02975	-3.37771916011048	1.0174264438244799e-131	M1_vs_M2	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693	NA	NA	SCIN
ENSG00000224397	PELATON	-1.0794785218894	1.8292187706890598e-42	M1_vs_M2	HSALNG0130749	integenic	Q50	hsa-miR-619-5p,hsa-miR-665,hsa-miR-4258,hsa-miR-4284,hsa-miR-4491,hsa-miR-4701-3p,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6132,hsa-miR-6748-3p,hsa-miR-6769b-5p,hsa-miR-6887-3p	Hair colour measurement,Monocyte percentage of leukocytes; Mammographic density measurement; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte count,Gut microbiome measurement,Monocyte percentage of leukocytes,Monocyte count,-	CEBPB	YBX1
ENSG00000224652	LINC00885	-2.18823077828159	6.0602695459073e-9	M1_vs_M2	HSALNG0031897	integenic	Not conserved	hsa-miR-920,hsa-miR-3169,hsa-miR-6133	Hba1c measurement,Mean corpuscular volume; Erythrocyte count,-	SLC51A	CDNF
ENSG00000224666	ETV7-AS1	5.41379865133122	0.00528664326098047	M1_vs_M2	HSALNG0049748	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4674,hsa-miR-6089	Rheumatoid arthritis,Leukocyte count,Mean platelet volume,Eczema; Allergic rhinitis,-	KCTD20	ENSG00000287335
ENSG00000224995	LINC01526	-2.40775743115008	4.62278606939085e-6	M1_vs_M2	HSALNG0051540	integenic	Q75	hsa-miR-761,hsa-miR-3619-5p,hsa-miR-6132	Loneliness measurement,Basophil count; Basophil percentage of leukocytes; Monocyte percentage of leukocytes,Coronary artery disease,Bmi-adjusted waist circumference,Cognitive function measurement,Body height,Myocardial infarction,Central corneal thickness,Intraocular pressure measurement,Adolescent idiopathic scoliosis,Bell's palsy,Bone density; Heel bone mineral density,Basophil count; Basophil percentage of leukocytes,Monocyte percentage of leukocytes,Central corneal thickness; Intraocular pressure measurement,Corneal resistance factor; Intraocular pressure measurement,Central corneal thickness; Corneal topography,Obsessive-compulsive disorder; Sex interaction measurement,Heel bone mineral density,-	TENT5A	URM1
ENSG00000225077	ICMT-DT	5.70715723356802	0.00338341180915279	M1_vs_M2	HSALNG0000511	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4650-5p,hsa-miR-6089	Qt interval,Resting heart rate,-	HES3	RASSF5
ENSG00000225138	SLC9A3-AS1	-1.20252550169558	1.14880276838467e-5	M1_vs_M2	HSALNG0039449	anti_sense	Q75	hsa-miR-762,hsa-miR-541-3p,hsa-miR-4279,hsa-miR-3619-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-4632-3p,hsa-miR-1343-5p,hsa-miR-4722-5p,hsa-miR-4749-3p,hsa-miR-5787,hsa-miR-6132,hsa-miR-6720-3p,hsa-miR-6747-5p,hsa-miR-6873-3p	-,Hemoglobin measurement	EXOC3	ENSG00000281920
ENSG00000225177	NHSL1-AS1	-2.91857657336159	2.97051955208735e-32	M1_vs_M2	HSALNG0053831	anti_sense	Q75	hsa-miR-345-5p,hsa-miR-1228-5p,hsa-miR-4534,hsa-miR-6816-5p	-	CCDC28A	NUDT19
ENSG00000225342	LRRK2-DT	2.76152757382844	1.24120952376492e-9	M1_vs_M2	HSALNG0090483	anti_sense	Q50	NA	Serum gamma-glutamyl transferase measurement,Crohn's disease,Mean platelet volume,Cathepsin l1 measurement,Low density lipoprotein cholesterol measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,-	SLC2A13	COL1A1
ENSG00000225434	LINC01504	-1.8312669111767	2.6933867535658402e-24	M1_vs_M2	HSALNG0071849	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4436a,hsa-miR-8485	Serum albumin measurement,Cognitive function measurement,-	GDA	LLGL1
ENSG00000225465	RFPL1S	1.15150511886421	0.0153018794429536	M1_vs_M2	HSALNG0134830	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-361-3p,hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-1268b,hsa-miR-4525,hsa-miR-6089,hsa-miR-6803-5p	Breast carcinoma,Upper aerodigestive tract neoplasm,-	THOC5	CCNY-AS1
ENSG00000225783	MIAT	2.37231777736632	6.6739493220015e-25	M1_vs_M2	HSALNG0134655	integenic	Q50	hsa-miR-216a-3p,hsa-miR-619-5p,hsa-miR-1285-5p,hsa-miR-4496,hsa-miR-4505,hsa-miR-4690-3p,hsa-miR-4726-3p,hsa-miR-5007-5p,hsa-miR-6089,hsa-miR-6754-5p,hsa-miR-6777-3p,hsa-miR-8485	Serum igg glycosylation measurement,Rr interval,Non-hodgkins lymphoma,Grey matter density measurement,Diet measurement,Gastroesophageal reflux disease,Self reported educational attainment; Cognitive function measurement,Cognitive function measurement; Mathematical ability,Intelligence,Lysophosphatidylethanolamine 18:1 measurement,Cognition,Electroencephalogram measurement; Theta wave measurement,Parental genotype effect measurement; Peanut allergy measurement,Covid-19; Pneumonia,Hypermetropia; Myopia,-	CRYBA4	NR1I2
ENSG00000225792	SNX10-AS1	4.51121106890139	5.695982484767629e-75	M1_vs_M2	HSALNG0056814	anti_sense	Q90	hsa-miR-4505,hsa-miR-1587,hsa-miR-3960	Bmi-adjusted waist-hip ratio,Blood urea nitrogen measurement; Bmi-adjusted waist circumference,Body weight; Body mass index,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vaginal microbiome measurement,-	HNRNPA2B1	ANKRD33B
ENSG00000225886	NA	5.26075989599656	8.36031290354038e-22	M1_vs_M2	HSALNG0002013	integenic	Not conserved	NA	NA	FAM76A	ZBTB2
ENSG00000225963	NA	1.62579436909132	2.11241985916207e-5	M1_vs_M2	HSALNG0022854	anti_sense	Q50	hsa-miR-6089,hsa-miR-6763-5p	Subcutaneous adipose tissue measurement,Metabolic rate measurement,Serum non-albumin protein measurement,Obsessive-compulsive disorder; Obsessive-compulsive symptom measurement,-	SP140	LARP4B
ENSG00000225964	NRIR	5.56694461581691	4.29994462736556e-60	M1_vs_M2	HSALNG0012717	integenic	Q75	NA	Depressive symptom measurement,-	CMPK2	XIRP1
ENSG00000226004	LINC02528	9.40928492241122	3.89503661323068e-39	M1_vs_M2	HSALNG0053802	integenic	Q50	NA	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP	PSTPIP2
ENSG00000226067	LINC00623	2.16183924525992	8.99920409972329e-7	M1_vs_M2	HSALNG0006641	integenic	Not conserved	NA	NA	PPIAL4A	ITK
ENSG00000226091	LINC00937	4.86060818204587	7.448350704665319e-84	M1_vs_M2	HSALNG0089057	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6735-5p	Viral load,-	FAM90A1	AMPD3
ENSG00000226137	BAIAP2-DT	-1.84098107911385	2.46112121911789e-69	M1_vs_M2	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK	MT-ND5
ENSG00000226239	NA	5.51844847230472	0.00466759329248656	M1_vs_M2	HSALNG0129532	anti_sense	Q50	NA	Cystatin c measurement,Cognitive decline measurement,-	PDRG1	LGALS14
ENSG00000226281	NA	-2.54381557329562	3.7836412969095294e-100	M1_vs_M2	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787	NA	F13A1	BRCC3
ENSG00000226312	CFLAR-AS1	1.36988733373415	2.38056698686257e-6	M1_vs_M2	HSALNG0021529	anti_sense	Q50	hsa-miR-30b-3p	Total blood protein measurement,-	HYCC2	TCHH
ENSG00000226328	NUP50-DT	1.06439089097186	2.57681200002048e-16	M1_vs_M2	HSALNG0135916	integenic	Q50	hsa-miR-4492,hsa-miR-6763-5p	Mean corpuscular hemoglobin concentration,-	KIAA0930	SYNC
ENSG00000226441	PLCL2-AS1	-3.55901798331704	0.00802316226557904	M1_vs_M2	HSALNG0024502	anti_sense	Q75	NA	NA	TBC1D5	CCL17
ENSG00000226777	FAM30A	-1.07110996976968	0.0169854582386161	M1_vs_M2	HSALNG0104257	integenic	Not conserved	NA	NA	TMEM121	LINC00863
ENSG00000226822	LINC02785	-1.86333283705039	7.32750226561265e-14	M1_vs_M2	HSALNG0005787	anti_sense	Q50	hsa-miR-1224-5p,hsa-miR-4508,hsa-miR-4638-3p,hsa-miR-6089	Bipolar disorder,Neutrophil count,Waist-hip ratio,Heel bone mineral density,Hba1c measurement,Hemoglobin a1 measurement,Mean corpuscular volume,Covid-19,Growth-regulated alpha protein measurement,Herpes zoster,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Forced expiratory volume; Response to bronchodilator,-	NBPF6	SLC39A6
ENSG00000226862	NA	-4.75230114809706	0.0313635395628436	M1_vs_M2	HSALNG0009734	anti_sense,sense	Q75	hsa-miR-328-3p,hsa-miR-574-5p,hsa-miR-4453,hsa-miR-4486	Cortical surface area measurement,-	PPP1R12B	ENSG00000274422
ENSG00000226950	DANCR	-1.03686205479827	5.80539645691728e-6	M1_vs_M2	HSALNG0148096	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7108-3p	Response to citalopram; Mood disorder; Response to escitalopram; Unipolar depression,-	RASL11B	PAK1IP1
ENSG00000227017	NA	4.51799752309781	2.17946285766459e-7	M1_vs_M2	HSALNG0056985	integenic	Q50	NA	-	FKBP14	VIM
ENSG00000227039	ITGB2-AS1	2.14149519894605	8.630438724276199e-31	M1_vs_M2	HSALNG0133581	anti_sense	Not conserved	hsa-miR-4456,hsa-miR-5090,hsa-miR-6732-5p	Heel bone mineral density,-	SLX9	CARD19
ENSG00000227066	NA	2.69488280612056	6.00720477332491e-4	M1_vs_M2	HSALNG0001417	integenic	Not conserved	NA	NA	PLA2G2F	ERF
ENSG00000227155	DOCK8-AS2	1.13461702620023	0.0118913489025336	M1_vs_M2	HSALNG0069538	anti_sense	Q90	hsa-miR-4268,hsa-miR-4743-3p	Bilirubin measurement,Hair morphology measurement,-	ZNG1A	YWHAH
ENSG00000227392	HPN-AS1	7.36096197759784	2.46415757001018e-9	M1_vs_M2	HSALNG0125567	anti_sense	Not conserved	NA	NA	LGI4	FBLN7
ENSG00000227502	MROCKI	3.57652835910988	3.6431222408497796e-25	M1_vs_M2	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505	NA	HDAC2	TNFRSF25
ENSG00000227531	NA	2.3279917444147	5.95573188488955e-4	M1_vs_M2	HSALNG0073676	integenic	Q50	hsa-miR-23a-5p,hsa-miR-619-5p,hsa-miR-6089,hsa-miR-7107-5p	Bmi-adjusted waist-hip ratio,Monocyte count,Bmi-adjusted hip circumference,Electrocardiography,Leukocyte count,Body height at birth; Birth weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Waist-hip ratio; Bmi-adjusted hip circumference; Myeloid white cell count; Bmi-adjusted waist-hip ratio; Monocyte count; Monocyte percentage of leukocytes,Late-onset alzheimers disease,Myeloid white cell count,Leukocyte count; Lymphocyte percentage of leukocytes,Monocyte percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Body height,Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Neutrophil percentage of leukocytes; Birth weight; Basophil count,Eosinophil count,Parental genotype effect measurement; Birth weight,Response to antineoplastic agent; Venous thromboembolism,-	OR2K2	MTF2
ENSG00000227544	LINC03013	-3.53922093870271	0.00558619471376031	M1_vs_M2	HSALNG0057229	integenic	Q90	hsa-miR-619-5p,hsa-miR-5006-3p	-	SEPTIN7	RYK
ENSG00000227917	NA	2.48061276119221	0.0202131417558274	M1_vs_M2	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	PDXDC1
ENSG00000228013	IL6R-AS1	2.4203950221487	1.62141232524238e-8	M1_vs_M2	HSALNG0007394	anti_sense	Q75	hsa-miR-4710,hsa-miR-6736-5p	C-reactive protein measurement,C-reactive protein measurement; Serum non-albumin protein measurement,Albumin:globulin ratio measurement,Total blood protein measurement,Serum non-albumin protein measurement,Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis,-	SHE	MDGA1
ENSG00000228022	HCG20	5.41473283314911	0.00980501746181051	M1_vs_M2	HSALNG0049198	integenic	Not conserved	NA	NA	TUBB	ENSG00000258509
ENSG00000228382	ITPKB-IT1	-3.17925891964975	0.0351924538823387	M1_vs_M2	HSALNG0011101	sense	Q75	NA	NA	ITPKB	ETAA1
ENSG00000228536	LYPLAL1-AS1	-5.34830871581357	0.0140569748013418	M1_vs_M2	HSALNG0010664	integenic	Q50	hsa-miR-4492,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lean body mass,Appendicular lean mass,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Triglyceride measurement; Aspartate aminotransferase measurement,Body mass index,Visceral:subcutaneous adipose tissue ratio; Body mass index,Body height,Body weight,Reticulocyte measurement; Bmi-adjusted hip circumference,Insulin measurement,Pulse pressure measurement; Obesity; Osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty,Visceral:subcutaneous adipose tissue ratio,Osteoarthritis, hip; Body mass index; Physical activity measurement; Bmi-adjusted waist-hip ratio; Fasting blood insulin measurement; Osteoarthritis, hip, osteoarthritis, knee,Waist-hip ratio,Hip circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement; Reticulocyte measurement; Bmi-adjusted hip circumference; Reticulocyte count,Red blood cell density measurement; Hemorrhoid; Erythrocyte count,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Nose morphology measurement,Bmi-adjusted waist-hip ratio; Physical activity measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement,High density lipoprotein cholesterol measurement,Open-angle glaucoma,Smoking behavior; Bmi-adjusted waist-hip ratio,Triglyceride measurement; High density lipoprotein cholesterol measurement,Adiponectin measurement,Apolipoprotein a 1 measurement,Body fat percentage; Bmi-adjusted hip circumference,Total blood protein measurement; High density lipoprotein cholesterol measurement,Astigmatism,Bmi-adjusted waist circumference; Drugs used in diabetes use measurement; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Physical activity measurement,Bmi-adjusted waist circumference; Appendicular lean mass,Varicose veins; Inguinal hernia,Acne; Bmi-adjusted hip circumference,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Body mass index; Adiponectin measurement; Fasting blood insulin measurement,Systolic blood pressure,Sex hormone-binding globulin measurement; Adiponectin measurement,-	ZC3H11B	DUOX2
ENSG00000228624	HDAC2-AS2	-1.43950364031774	4.96257907113522e-7	M1_vs_M2	HSALNG0052943	integenic	Not conserved	NA	NA	MARCKS	SORT1
ENSG00000228742	LINC02577	-1.87329598548749	8.01549178348847e-4	M1_vs_M2	HSALNG0060386	integenic	Not conserved	hsa-miR-4281,hsa-miR-4710	Eosinophil count,Agents acting on the renin-angiotensin system use measurement,Systolic blood pressure; Common carotid intimal medial thickness; Alcohol drinking,Diuretic use measurement,Systolic blood pressure; Mean arterial pressure,Eosinophil percentage of leukocytes,Cognitive inhibition measurement,-	PIK3CG	ZFAND6
ENSG00000228863	NA	3.05562746917285	2.0239833996792498e-11	M1_vs_M2	HSALNG0007856	anti_sense	Not conserved	hsa-miR-4776-3p	Moderate albuminuria,-	SLAMF7	FAM217B
ENSG00000228923	NA	5.87400255965057	4.32751433264362e-4	M1_vs_M2	HSALNG0134504	sense	Q75	hsa-miR-6810-3p	Serum gamma-glutamyl transferase measurement	UPB1	LGALS14
ENSG00000229140	CCDC26	-5.50081824144873	1.21940655178497e-62	M1_vs_M2	HSALNG0068551	integenic	Q50	hsa-miR-575,hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-4287,hsa-miR-4328,hsa-miR-3677-3p,hsa-miR-6809-3p,hsa-miR-6873-3p,hsa-miR-6892-3p,hsa-miR-8485	Dna methylation,Eczema,Balding measurement,Heel bone mineral density,Lip morphology measurement,Facial morphology measurement,Unipolar depression,Creatinine measurement,Cleft lip; Oral cleft; Cleft palate,Myeloid white cell count,Cleft lip; Progranulin measurement,Cortical surface area measurement; Cortical thickness,Alkaline phosphatase measurement,Cleft lip; Neuroimaging measurement; Heel bone mineral density; Blood phosphate measurement; Cleft palate; Brain measurement,Cleft lip; Oral cleft,Lung adenocarcinoma,Leukocyte count,Neutrophil count,Cleft lip,Eosinophil count,Vital capacity,Self reported educational attainment,Forced expiratory volume,Mathematical ability,Fev/fec ratio,Acute lymphoblastic leukemia,Body height,Monocyte count,Monocyte percentage of leukocytes,B-cell acute lymphoblastic leukemia,Gut microbiome measurement,Creatinine measurement; Glomerular filtration rate,Nicotine dependence,Glioma,Central nervous system cancer,Hypospadias,Urate measurement,Lateral occipital cortex volume measurement,Uterine fibroid,Platelet count; Platelet crit,Indole-3-propionate measurement,Bullous pemphigoid,Cortical surface area measurement,Mitochondrial dna measurement,Inflammatory bowel disease; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Monocyte count; Mean corpuscular volume,Leukocyte count; Monocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Eosinophil count; Monocyte count; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Neutrophil-to-lymphocyte ratio,Cortical thickness,Leukocyte count; Neutrophil count; Myeloid white cell count,Neutrophil percentage of leukocytes; Mean corpuscular hemoglobin,Mosaic loss of chromosome y measurement,Resistin measurement; Myeloperoxidase measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Leukocyte count; Neutrophil count; Monocyte count,Neutrophil percentage of granulocytes; Neutrophil percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Inflammatory bowel disease; Ulcerative colitis; Monocyte count; Monocyte:lymphocyte ratio; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Adolescent idiopathic scoliosis,Monocyte count; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil count; Basophil count; Leukocyte count; Eosinophil count; Granulocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Monocyte count,Erythrocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Neutrophil count; Myeloid white cell count,Red blood cell density measurement,Mean reticulocyte volume,Neutrophil percentage of leukocytes,Basophil percentage of granulocytes; Educational attainment; Basophil count; Basophil percentage of leukocytes,Granulocyte percentage of myeloid white cells,Eye color,Monocyte percentage of leukocytes; Monocyte count,Neuroimaging measurement; Glioblastoma multiforme; Glioma; White matter microstructure measurement; Brain volume measurement; Age at onset; Central nervous system cancer,Platelet count,Basophil count,Retinopathy,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Myeloid white cell count,Basophil count; Eosinophil percentage of leukocytes,Platelet crit,Eosinophil count; Eosinophil percentage of leukocytes,Response to methotrexate; Juvenile idiopathic arthritis,Cleft lip; Cleft palate,Unipolar depression; Endometriosis,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	GSDMC	METTL9
ENSG00000229272	LINC03036	-4.18136530580908	9.253268082998679e-12	M1_vs_M2	HSALNG0081008	integenic	Not conserved	NA	NA	EIF3A	CCDC86
ENSG00000229331	GK-IT1	3.19629185938023	1.48850458138742e-4	M1_vs_M2	HSALNG0137205	intronic_sense	Not conserved	hsa-miR-619-5p	NA	GK	TAF1C
ENSG00000229337	NA	1.70609441093503	0.00530352755981589	M1_vs_M2	HSALNG0146662	integenic	Not conserved	NA	NA	NFE2L2	ENSG00000289351
ENSG00000229400	CNIH3-AS1	4.69991156808943	1.81202480182426e-13	M1_vs_M2	HSALNG0010970	anti_sense	Q50	NA	Mortality,White matter microstructure measurement,-	WDR26	TEAD2
ENSG00000229484	LINC02766	-2.17905339639811	9.67239099679452e-5	M1_vs_M2	HSALNG0000944	integenic	Not conserved	NA	-	VPS13D	FOLR1
ENSG00000229525	DNPEP-AS1	-4.78935832631141	0.0462809721728222	M1_vs_M2	HSALNG0022376	anti_sense,sense	Q50	NA	-	DES	TLCD2
ENSG00000229664	NA	5.6152707605471	0.00391672220094267	M1_vs_M2	HSALNG0075911	anti_sense	Not conserved	hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6873-3p	Liver fibrosis measurement; Epstein barr virus nuclear antigen 1 igg measurement,Response to diisocyanate,Interleukin 2 receptor antagonist measurement,Crohn's disease; Inflammatory bowel disease,Hypothyroidism; Thyroid preparation use measurement,Eosinophil count; Respiratory system disease; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Ovarian serous carcinoma; Response to carboplatin; Response to paclitaxel; Progression free survival,-	RBM17	DKK3
ENSG00000229771	NA	-3.09110540432548	6.634123829270461e-63	M1_vs_M2	HSALNG0130126	integenic	Q90	NA	Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement	MAFB	CD37
ENSG00000229922	LINC02865	5.52011795398512	0.0117282065623473	M1_vs_M2	HSALNG0053801	integenic	Q50	hsa-miR-6873-3p	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,Phosphatidylcholine ether measurement,-	TNFAIP3	ENSG00000232680
ENSG00000229931	ATXN1-AS1	-1.99253450238742	4.70730807983857e-9	M1_vs_M2	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	SMIM13
ENSG00000229953	BCAN-AS2	-1.23035406793861	0.0152513138687227	M1_vs_M2	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	LAMC1
ENSG00000230061	TRPM2-AS	1.85976797085101	0.0166022240654108	M1_vs_M2	HSALNG0133533	anti_sense	Q50	hsa-miR-4486,hsa-miR-6888-5p,hsa-miR-7110-5p	-	TSPEAR	NABP1
ENSG00000230107	NA	2.69499247219063	9.62148906416821e-8	M1_vs_M2	HSALNG0135708	integenic	Q90	hsa-miR-3158-5p,hsa-miR-4650-5p,hsa-miR-4691-5p,hsa-miR-6089,hsa-miR-6132	NA	SERHL2	TMEM176A
ENSG00000230303	NA	-2.53330544081818	0.0341336779458089	M1_vs_M2	HSALNG0072359	integenic	Not conserved	NA	Viral load,-	AGTPBP1	ENSG00000286787
ENSG00000230438	SERPINB9P1	1.85276973796289	1.75071740676171e-50	M1_vs_M2	HSALNG0047525	integenic	Not conserved	NA	NA	SERPINB9	CYBC1
ENSG00000230479	NA	-2.09430823386951	0.00918629166412099	M1_vs_M2	HSALNG0132951	integenic	Not conserved	NA	NA	CHAF1B	FARSB
ENSG00000230487	PSMG3-AS1	-1.21218028470565	2.3158544229950804e-15	M1_vs_M2	HSALNG0055664	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-762,hsa-miR-1268b,hsa-miR-5589-5p,hsa-miR-6089	-	MAFK	LINC02685
ENSG00000230537	LINC02937	-5.18717894809126	0.0129389489460809	M1_vs_M2	HSALNG0072707	integenic	Not conserved	NA	Eosinophil count	AUH	KCNH3
ENSG00000230555	LINC02916	-1.08255978946197	0.0154382898720813	M1_vs_M2	HSALNG0077549	integenic	Q50	hsa-miR-619-5p	NA	ZNF487	VAV2
ENSG00000230647	NA	8.02441022411005	3.77283161672689e-14	M1_vs_M2	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1	ENSG00000230647
ENSG00000230747	NA	-2.5738985331839	1.4742836721233201e-9	M1_vs_M2	HSALNG0017036	sense	Not conserved	NA	Hemoglobin a1 measurement; Unipolar depression,-	SNRNP200	ENSG00000272768
ENSG00000230825	LINC03016	4.7345045209793	0.0485525059652669	M1_vs_M2	HSALNG0056038	integenic	Q50	hsa-miR-619-5p,hsa-miR-4290	Smooth surface dental caries,Daytime rest measurement,Body mass index; Visceral adipose tissue measurement	C1GALT1	LINC02068
ENSG00000230838	LINC01614	-5.20131762116096	1.24010242647267e-45	M1_vs_M2	HSALNG0022084	integenic	Q50	NA	Kynurenine measurement,Bmi-adjusted waist circumference; Body height,Bmi-adjusted waist circumference,Facial width measurement,Heel bone mineral density,-	TMEM169	TBCK
ENSG00000230943	LINC02541	2.38200259203642	1.95729594435727e-10	M1_vs_M2	HSALNG0052910	integenic	Not conserved	NA	NA	HDAC2	ICMT
ENSG00000231131	LNCAROD	3.04831189565946	1.27421545216126e-8	M1_vs_M2	HSALNG0078017	integenic	Not conserved	hsa-miR-6895-5p	Heel bone mineral density,Bone density; Dickkopf‐related protein 1 measurement; Heel bone mineral density,Bone density,Bone density; Heel bone mineral density,Dickkopf‐related protein 1 measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone fracture,Velocity of sound measurement; Bone quantitative ultrasound measurement; Heel bone mineral density,Bone quantitative ultrasound measurement	MBL2	CYB5R4
ENSG00000231233	CFAP58-DT	1.2623997746366	6.73388438681276e-4	M1_vs_M2	HSALNG0080427	integenic	Q50	NA	NA	ITPRIP	F5
ENSG00000231346	LINC01160	-3.27769711180537	6.00760520098874e-50	M1_vs_M2	HSALNG0006063	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6089	Leukocyte count,Lymphocyte count,-	TMIGD3	MAP1S
ENSG00000231528	FAM225A	3.67476042144524	1.8096449665859301e-32	M1_vs_M2	HSALNG0073810	integenic	Not conserved	NA	NA	SLC31A2	FICD
ENSG00000231574	LINC02015	3.97729741420059	8.34137161804218e-9	M1_vs_M2	HSALNG0030884	integenic	Q50	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4456,hsa-miR-4508,hsa-miR-6749-5p,hsa-miR-6807-3p,hsa-miR-7703,hsa-miR-4433b-3p,hsa-miR-8485	Systemic lupus erythematosus,Hba1c measurement; Hemoglobin a1 measurement,Hallux valgus,Anxiety disorder,Reaction time measurement,Visual perception measurement,Alcohol drinking,Unipolar depression,Brain volume measurement,Cortical surface area measurement,Chin morphology measurement,Corneal topography,Central corneal thickness,Cortical thickness,Heel bone mineral density,Cortical surface area measurement; Neuroimaging measurement,White matter microstructure measurement,Body height,Calcium measurement,Lobe attachment,Neuropsychological test,Venous thromboembolism,Pathological myopia,Gut microbiome measurement,Adolescent idiopathic scoliosis,Abnormality of the urinary system; Response to radiation,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Ovarian serous carcinoma; Ovarian carcinoma; Progression free survival,Response to cranial radiation therapy; Body mass index,-	KCNMB2	LINC00472
ENSG00000231663	COA6-AS1	-1.83027547198073	0.0324793836941942	M1_vs_M2	HSALNG0011591	anti_sense	Q50	hsa-miR-6763-5p	-	TARBP1	SLC25A5-AS1
ENSG00000231672	DIRC3	-1.80773588007174	4.48997259925618e-6	M1_vs_M2	HSALNG0022200	integenic	Not conserved	NA	NA	TNS1	SDCBP
ENSG00000231808	LINC01388	1.48456320378989	6.168677798519e-4	M1_vs_M2	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	H2BC8
ENSG00000231856	NA	2.19996909368624	0.0347208269907774	M1_vs_M2	HSALNG0097204	anti_sense	Not conserved	hsa-miR-4530,hsa-miR-5089-5p	-	WDFY2	PALMD
ENSG00000231858	STAT4-AS1	6.77997667159484	5.42982155929795e-7	M1_vs_M2	HSALNG0021145	anti_sense	Q75	hsa-miR-3666	-	GLS	HLA-DOB
ENSG00000232053	NA	1.00865730048174	0.008350023025759	M1_vs_M2	HSALNG0061598	integenic	Q75	hsa-miR-663b	NA	STMP1	FUT8
ENSG00000232093	DCST1-AS1	-1.78599204782194	0.0226696610238462	M1_vs_M2	HSALNG0007463	anti_sense	Q50	hsa-miR-1207-5p	Calcium measurement; Serum urea measurement; Serum albumin measurement,Hba1c measurement,Dna methylation,Serum gamma-glutamyl transferase measurement; Urate measurement,Forehead morphology measurement,Bmi-adjusted hip circumference,Blood protein measurement; Smoking status measurement,Skin neoplasm,Gait measurement,Eosinophil percentage of leukocytes,Varicose veins; Chin morphology measurement; Cortical surface area measurement; Mosquito bite reaction size measurement; Facial morphology measurement; Serum albumin measurement; Risk-taking behaviour,Attention deficit hyperactivity disorder; Systemic lupus erythematosus; Smoking status measurement; Substance abuse; Risk-taking behaviour; Antisocial behaviour measurement,-	DCST2	TRPV5
ENSG00000232160	RAP2C-AS1	1.27932204004331	0.0132114172355493	M1_vs_M2	HSALNG0140185	integenic	Not conserved	NA	NA	STK26	UBE2FP1
ENSG00000232295	NA	1.0051695772609	0.0333872292548426	M1_vs_M2	HSALNG0051162	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6803-5p,hsa-miR-6813-5p	Antipsychotic drug related weight gain; Longitudinal bmi measurement,Beta-amyloid 1-42 measurement,Heel bone mineral density,Lung carcinoma,Body height,-	B3GAT2	ENSG00000291064
ENSG00000232310	LINC03002	-2.4112471129127	0.00100649899199693	M1_vs_M2	HSALNG0053635	integenic	Q75	hsa-miR-6838-5p	NA	SGK1	DCAF1
ENSG00000232453	LINC02777	-1.04737111270314	1.88741350754187e-10	M1_vs_M2	HSALNG0003962	integenic	Not conserved	NA	Bmi-adjusted hip circumference,-	JUN	RBM7
ENSG00000232485	RPL37A-DT	-1.4482699278125	2.61987982337223e-5	M1_vs_M2	HSALNG0022128	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4286	-	MARCHF4	HLA-DPA3
ENSG00000232545	NA	1.4918795597884	0.00590894777425169	M1_vs_M2	HSALNG0134472	sense	Q90	hsa-miR-4529-5p,hsa-miR-6132	NA	CABIN1	NDRG2
ENSG00000232618	HIVEP2-DT	6.55331080249541	2.70068592394617e-5	M1_vs_M2	HSALNG0054003	anti_sense	Q50	hsa-miR-4279	Mean platelet volume,-	AIG1	HIVEP2-DT
ENSG00000232656	IDI2-AS1	1.08693287999707	0.00558140089761628	M1_vs_M2	HSALNG0075528	anti_sense	Q75	hsa-miR-3940-5p,hsa-miR-4433a-3p	Response to candesartan,-	GTPBP4	C8orf76
ENSG00000232680	NA	5.52013261270846	0.0119520632169224	M1_vs_M2	HSALNG0125614	integenic	Not conserved	NA	NA	KRTDAP	ENSG00000232680
ENSG00000232912	RERE-AS1	2.98507105990348	5.10648958613518e-8	M1_vs_M2	HSALNG0000636	anti_sense	Q50	hsa-miR-920,hsa-miR-4447,hsa-miR-4505	Self reported educational attainment,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Thyroid peroxidase antibody measurement; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,Diastolic blood pressure; Depressive symptom measurement; Basophil count; Unipolar depression; Smoking status measurement; Eosinophil count; Vitiligo,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Tourette syndrome; Aspartate aminotransferase measurement,Body fat percentage,Cup-to-disc ratio measurement; Systolic blood pressure,Open-angle glaucoma,Autism spectrum disorder,Self reported educational attainment; Intelligence,Wellbeing measurement,-	SLC45A1	ACAP3
ENSG00000232956	SNHG15	1.47077152383184	9.08433821523222e-31	M1_vs_M2	HSALNG0057702	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-7107-5p	Body height,Diastolic blood pressure,-	MYO1G	AFTPH-DT
ENSG00000233029	NA	5.70739764329559	0.00272266592733002	M1_vs_M2	HSALNG0142289	anti_sense	Not conserved	NA	-	FAM72B	ENSG00000254287
ENSG00000233030	NA	7.52005785483748	2.1867552676302197e-11	M1_vs_M2	HSALNG0142341	anti_sense,intronic_sense	Not conserved	NA	Monocyte count,-	H2BC18	TFAP2C
ENSG00000233077	LINC01271	2.31995179273501	1.71610808522265e-7	M1_vs_M2	HSALNG0130754	integenic	Q50	hsa-miR-6875-3p	Thyroid stimulating hormone measurement,Monocyte count,-	PEDS1	FOXRED1
ENSG00000233175	FMNL1-AS1	2.54746618252757	0.0373345026973112	M1_vs_M2	HSALNG0116843	anti_sense	Q90	hsa-miR-4286	-	SPATA32	STEAP4
ENSG00000233237	LINC00472	4.02372876869718	2.3369648441053697e-16	M1_vs_M2	HSALNG0051173	integenic	Q50	NA	NA	B3GAT2	LINC02015
ENSG00000233251	NA	-5.02414702317304	0.0261123968749263	M1_vs_M2	HSALNG0015066	anti_sense	Q50	hsa-miR-4279,hsa-miR-4472	Lysophosphatidylcholine 18:2 measurement; Lysophosphatidylcholine 18:1 measurement,Cleft lip,-	EFEMP1	ASCL1
ENSG00000233360	PDXP-DT	1.80703907245282	0.0252767222063126	M1_vs_M2	HSALNG0135333	anti_sense	Q75	hsa-miR-6749-3p	-	LGALS2	EIF3B
ENSG00000233384	CNIH3-AS2	-2.03613239218422	1.37478935857871e-10	M1_vs_M2	HSALNG0010968	anti_sense	Q75	hsa-miR-4467,hsa-miR-3960,hsa-miR-7156-3p	-	WDR26	MKLN1
ENSG00000233392	UICLM	-7.98458907730395	2.25328901164734e-15	M1_vs_M2	HSALNG0023633	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-4492,hsa-miR-6791-5p	NA	MAB21L4	ENSG00000286584
ENSG00000233559	LINC00513	-1.75598932387058	0.00124682662680641	M1_vs_M2	HSALNG0061393	integenic	Not conserved	NA	Parental genotype effect measurement; Vitamin d measurement	MKLN1	JDP2-AS1
ENSG00000233610	LINC00462	5.17878576558645	0.0151975151700522	M1_vs_M2	HSALNG0097004	anti_sense	Not conserved	NA	NA	RCBTB2	SEC63
ENSG00000233613	DCUN1D2-AS	-2.74328982823049	0.0339425361530272	M1_vs_M2	HSALNG0099596	anti_sense	Not conserved	NA	Neutrophil count; Monocyte percentage of leukocytes,-	TMCO3	PAXIP1-DT
ENSG00000233621	ZC3H12A-DT	1.50643962320601	7.35931536171352e-32	M1_vs_M2	HSALNG0002623	integenic	Not conserved	NA	NA	MEAF6	PRMT5
ENSG00000233785	NA	2.38406600895226	0.00129756066116162	M1_vs_M2	HSALNG0137010	sense	Q75	hsa-miR-619-5p	Shoulder impingement syndrome; Rotator cuff tear,Ribose-5-phosphate measurement; Ribulose-5-phosphate measurement	ACOT9	ENSG00000267074
ENSG00000233818	CLDN14-AS1	-2.76624369270572	6.47284258789269e-8	M1_vs_M2	HSALNG0132951	integenic	Not conserved	NA	NA	CHAF1B	LGALS8
ENSG00000233901	LINC01503	-2.03186716841727	7.174833376449009e-19	M1_vs_M2	HSALNG0074718	integenic	Q75	hsa-miR-185-3p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4530,hsa-miR-1587,hsa-miR-6089,hsa-miR-6732-5p,hsa-miR-6791-5p,hsa-miR-8485	Atopic eczema,Protein measurement,Caudate nucleus measurement; Functional brain measurement; Response to reward,-	NA	RTP4
ENSG00000233975	LINC02574	5.94992458424511	9.4844860602983e-4	M1_vs_M2	HSALNG0002009	integenic	Q50	hsa-miR-619-5p	Body weight,Systolic blood pressure; Pulse pressure measurement; Mean arterial pressure,Body mass index,-	IFI6	LINC02574
ENSG00000234142	LINC01675	5.874003709449	5.01206428171047e-4	M1_vs_M2	HSALNG0008185	integenic	Q75	NA	-	FAM78B	LINC01597
ENSG00000234147	NA	-3.58147333932358	2.93625314253235e-8	M1_vs_M2	HSALNG0053918	integenic	Q75	hsa-miR-4281,hsa-miR-6776-5p,hsa-miR-8485	3-hydroxypropylmercapturic acid measurement,Susceptibility to bacterial meningitis measurement,Sleep quality,Facial emotion recognition measurement,Response to diisocyanate,Acute lymphoblastic leukemia,Systolic blood pressure change measurement; Response to hydrochlorothiazide,Fev/fec ratio,Reaction time measurement,-	NMBR	SYVN1
ENSG00000234177	LINC01114	-4.03499951122285	6.5568792605159e-4	M1_vs_M2	HSALNG0017537	anti_sense	Q90	hsa-miR-328-3p,hsa-miR-3196,hsa-miR-8485	Chronotype measurement,Pancreatic carcinoma,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Body mass index,Body weight,Mean arterial pressure,Lifestyle measurement; Neuroimaging measurement; Body mass index; Brain measurement; Body height,Brain volume measurement,-	TGFBRAP1	FBXO16
ENSG00000234211	NA	-4.992013719865	0.0173694817139023	M1_vs_M2	HSALNG0007963	anti_sense	Q75	NA	Rheumatoid arthritis,Aspartate aminotransferase measurement,Erythrocyte count,Monocyte percentage of leukocytes,-	FCGR3B	DUOX2
ENSG00000234327	ZNF232-AS1	-1.28424583375786	0.00140565926882222	M1_vs_M2	HSALNG0114103	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-3162-5p,hsa-miR-1268b	-	ZFP3	RN7SL23P
ENSG00000234389	NA	6.77964530759432	1.09481892670684e-6	M1_vs_M2	HSALNG0017421	sense	Not conserved	hsa-miR-6811-3p	NA	IL18RAP	GADD45B
ENSG00000234394	LINC03025	7.08125023567654	6.56760886763319e-7	M1_vs_M2	HSALNG0071679	sense	Q50	hsa-miR-762,hsa-miR-4447,hsa-miR-5787,hsa-miR-6124	-	PGM5	SAA1
ENSG00000234432	LINC02983	-3.35108035435822	2.90810201286158e-5	M1_vs_M2	HSALNG0149872	integenic	Q50	hsa-miR-4733-3p	-	TNRC18	HHATL
ENSG00000234456	MAGI2-AS3	2.79352058107605	1.1123510977490001e-48	M1_vs_M2	HSALNG0059170	anti_sense	Q75	hsa-miR-339-5p,hsa-miR-4447,hsa-miR-3960,hsa-miR-5001-3p,hsa-miR-6749-3p,hsa-miR-6786-5p,hsa-miR-8485	-	GNAI1	C1QA
ENSG00000234506	LINC01506	-1.3297020958851	0.0228634164781032	M1_vs_M2	HSALNG0071693	integenic	Not conserved	hsa-miR-5787	NA	TMEM252	TRAF6
ENSG00000234572	LINC01800	-3.81853959629059	8.09428287441869e-29	M1_vs_M2	HSALNG0015493	integenic	Q50	hsa-miR-27a-5p,hsa-miR-200c-5p,hsa-miR-7113-3p	Cholesteryl ester 22:6 measurement,Ccl2 measurement,Visceral adipose tissue measurement,Dna methylation,Epithelial cell adhesion molecule measurement,Sex hormone-binding globulin measurement,Obstructive sleep apnea; Sleep apnea measurement,Protein measurement,Monocyte percentage of leukocytes,-	SERTAD2	WDR55
ENSG00000234630	NA	-2.23321143779657	0.0210526447668949	M1_vs_M2	HSALNG0134317	integenic	Not conserved	hsa-miR-874-3p,hsa-miR-6775-3p	NA	VPREB1	VRK1
ENSG00000234807	LINC01135	-3.67078893878322	5.512903747740819e-136	M1_vs_M2	HSALNG0003956	anti_sense	Q50	hsa-miR-497-5p,hsa-miR-504-3p,hsa-miR-922,hsa-miR-3197,hsa-miR-5587-3p,hsa-miR-5787,hsa-miR-6722-3p,hsa-miR-6728-3p,hsa-miR-6829-3p,hsa-miR-6873-3p,hsa-miR-7108-3p	Aminoadipic acid measurement,Neuropsychological test,Empathy measurement,Sleep duration,-	FGGY	CRYZ
ENSG00000234869	LINC02925	-2.17055964082069	1.42050133261212e-5	M1_vs_M2	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4	ENSG00000287893
ENSG00000234883	MIR155HG	1.73850080624866	2.18598530890507e-27	M1_vs_M2	HSALNG0132382	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-8485	Neuropsychological test,Intelligence,Response to carboplatin,Nicotine dependence symptom count,Gout,Open-angle glaucoma,Triglyceride measurement,Erythrocyte count,Chronic lymphocytic leukemia,Cerebrospinal fluid biomarker measurement; Alpha synuclein measurement,Duchenne muscular dystrophy; Disease progression measurement,-,Amyloid plaque accumulation rate	JAM2	ENSG00000202533
ENSG00000234919	LINC01827	-3.2359080845151	1.93804691451323e-7	M1_vs_M2	HSALNG0021276	anti_sense	Q50	hsa-miR-4463,hsa-miR-6825-5p,hsa-miR-1273h-5p	Neuroticism measurement; Temperament and character inventory,Intelligence,Ankle injury,Food allergy measurement,Response to benznidazole,Eye colour measurement,Gut microbiome measurement,Parental longevity,Proliferative diabetic retinopathy,Blood urea nitrogen measurement,Abnormality of chromosome segregation,Interleukin 2 measurement,Lymphoid leukemia,Bipolar disorder; Attention deficit hyperactivity disorder,Response to thiopurine; Leukopenia,Response to antimicrotubule agent; Response to antineoplastic agent,-	DNAH7	RBM12B
ENSG00000235215	NA	3.12893761226047	0.0148163084529148	M1_vs_M2	HSALNG0003965	integenic	Not conserved	NA	Excessive daytime sleepiness measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Protein measurement,Intelligence; Verbal-numerical reasoning measurement,Mathematical ability,Fat body mass,Platinum measurement; Response to cisplatin,-	JUN	MRPL50
ENSG00000235257	ITGA9-AS1	-3.44353387349631	4.39176652938725e-5	M1_vs_M2	HSALNG0025195	anti_sense	Not conserved	NA	NA	PLCD1	KLHL12
ENSG00000235314	LINC00957	-1.11157785686443	1.85893570616522e-4	M1_vs_M2	HSALNG0057613	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4466,hsa-miR-4505,hsa-miR-5585-3p,hsa-miR-6747-3p,hsa-miR-6784-5p	-	DBNL	KIF5C
ENSG00000235381	NA	-1.3040533954406	0.0158714875196831	M1_vs_M2	HSALNG0054500	anti_sense,sense	Q90	NA	-	TFB1M	OIP5-AS1
ENSG00000235407	CYMP-AS1	-4.75174557675254	0.031807136580798	M1_vs_M2	HSALNG0005984	integenic	Not conserved	NA	-	KCNA10	CYMP-AS1
ENSG00000235478	LINC01664	-4.30780844417702	2.0342760842782e-4	M1_vs_M2	HSALNG0133870	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4279,hsa-miR-6132	Aging,Emotional symptom measurement,-	IL17RA	H2BC26
ENSG00000235513	L3MBTL2-AS1	3.34212668539863	7.543337934249059e-31	M1_vs_M2	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL	SIX5
ENSG00000235531	MSC-AS1	1.94918894229757	5.8891294802610184e-43	M1_vs_M2	HSALNG0066120	anti_sense	Not conserved	NA	Lung carcinoma,Gout,Clinical treatment,Attention deficit hyperactivity disorder,Smoking behaviour measurement,Mental development measurement,Diastolic blood pressure,Forced expiratory volume; Response to bronchodilator,-	KCNB2	ZSCAN25
ENSG00000235545	DOCK7-DT	-4.06259810611556	1.55410178404161e-4	M1_vs_M2	HSALNG0004080	anti_sense	Q50	NA	Serum metabolite measurement,High density lipoprotein cholesterol measurement,Platelet count,Triglyceride measurement,Mean corpuscular volume,Bilirubin measurement; Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Triglyceride measurement,Blood metabolite measurement,Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Triglyceride measurement,Bilirubin measurement,-	ATG4C	NUDT4
ENSG00000235641	LINC00484	-4.84193274830233	0.0401366906738541	M1_vs_M2	HSALNG0072704	integenic	Q50	hsa-miR-619-5p,hsa-miR-644a,hsa-miR-4258,hsa-miR-4466,hsa-miR-4685-3p,hsa-miR-6803-5p,hsa-miR-6837-3p,hsa-miR-7704,hsa-miR-8069	Balding measurement,Platelet crit,Platelet count,Ulcerative colitis; Inflammatory bowel disease,Eczema,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Neutrophil percentage of granulocytes,Eosinophil percentage of leukocytes,Eosinophil count,Parental genotype effect measurement; Gestational blood glucose measurement; Glycosuria,Leukocyte count,-	SYK	LINC00484
ENSG00000235703	EOLA2-DT	-1.13080317557076	3.00546278837661e-6	M1_vs_M2	HSALNG0140629	integenic	Q50	hsa-miR-4640-3p	NA	HSFX4	RICTOR
ENSG00000235770	LINC00607	-1.99088966713378	4.25994164018164e-9	M1_vs_M2	HSALNG0022091	integenic	Not conserved	NA	-	MREG	TAOK2
ENSG00000235823	OLMALINC	1.12764658654764	3.07399905810155e-6	M1_vs_M2	HSALNG0080102	sense	Q50	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6089	Alkaline phosphatase measurement,-	SCD	SEPHS2
ENSG00000235910	APOA1-AS	2.55003200181423	0.0138691581176025	M1_vs_M2	HSALNG0087417	anti_sense	Not conserved	NA	Blood protein measurement,High density lipoprotein cholesterol measurement,Sleep duration; Triglyceride measurement,Serum metabolite measurement,Apolipoprotein a 1 measurement; Total cholesterol measurement; High density lipoprotein cholesterol measurement,-	APOC3	MKNK2
ENSG00000235979	NA	-5.51599544640188	0.00585594025602856	M1_vs_M2	HSALNG0115130	integenic	Not conserved	NA	NA	MFAP4	PRDM5
ENSG00000236404	VLDLR-AS1	-4.78909074985871	0.0335053468462181	M1_vs_M2	HSALNG0150761	integenic	Q50	hsa-miR-4463	NA	PUM3	EIF4BP9
ENSG00000236700	LINC01010	-1.49154955088514	4.33126662091371e-70	M1_vs_M2	HSALNG0053623	integenic	Q50	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-4430,hsa-miR-6089	Dental caries,-	TBPL1	CEP135
ENSG00000236790	LINC00299	5.79246416212248	0.00165562496311817	M1_vs_M2	HSALNG0012827	integenic	Not conserved	hsa-miR-761	NA	KIDINS220	NASP
ENSG00000236841	NA	-3.38203272533435	0.0145878021022138	M1_vs_M2	HSALNG0020020	overlap_antisense,anti_sense	Q90	NA	Cognitive function measurement; Mathematical ability,-	GCA	PLEK2
ENSG00000236846	NA	-6.01345052671598	8.63232172680923e-4	M1_vs_M2	HSALNG0010877	integenic	Q50	hsa-miR-22-3p,hsa-miR-3192-5p,hsa-miR-4472,hsa-miR-6780a-3p	NA	DISP1	TIMMDC1-DT
ENSG00000236901	MIR600HG	-1.0444839238864	3.75678323565615e-10	M1_vs_M2	HSALNG0074272	sense	Not conserved	NA	-	STRBP	ENSG00000279278
ENSG00000236914	LINC01852	3.21576234737743	0.0113065765022567	M1_vs_M2	HSALNG0105101	integenic	Q90	hsa-miR-7703	Body height,-	RASGRP1	ANKUB1
ENSG00000236939	BAALC-AS2	3.30074391247431	4.3756395178560296e-35	M1_vs_M2	HSALNG0067505	anti_sense	Q50	hsa-miR-4447	Pelvic organ prolapse,Cognitive function measurement,Myopia,Late-onset alzheimers disease,Mathematical ability,Colorectal cancer; Breast carcinoma,Triglyceride measurement; Response to diuretic,Hemoglobin a1 measurement,-	AZIN1	ENSG00000288954
ENSG00000237248	LINC00987	2.47682739212943	0.0442760200497475	M1_vs_M2	HSALNG0089130	integenic	Q50	hsa-miR-619-5p,hsa-miR-6769b-5p	-	KLRG1	ENSG00000280353
ENSG00000237310	LINC03011	-1.01750450612902	0.0173035264632771	M1_vs_M2	HSALNG0058603	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-6782-5p,hsa-miR-6803-5p,hsa-miR-6833-3p	-	TPST1	HEATR3
ENSG00000237352	LINC01358	3.87903773763787	9.07555256066639e-27	M1_vs_M2	HSALNG0003970	integenic	Q50	NA	Serum albumin measurement,Response to lithium ion; Bipolar disorder,Hematocrit; Pulse pressure measurement,-	FGGY	CSF3
ENSG00000237372	NA	4.22847000687794	1.0983970221583e-30	M1_vs_M2	HSALNG0072619	integenic	Not conserved	NA	NA	GADD45G	PMEPA1
ENSG00000237499	WAKMAR2	2.35804013719125	1.35742801441081e-10	M1_vs_M2	HSALNG0053791	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-6728-3p,hsa-miR-6803-5p,hsa-miR-6842-3p	Systemic lupus erythematosus,Total blood protein measurement,Eosinophil count,Eczema; Allergic rhinitis,Rheumatoid arthritis; Systemic lupus erythematosus,C-reactive protein measurement,-	PERP	ENSG00000290041
ENSG00000237525	NA	-5.42985720871618	1.6844844158959498e-23	M1_vs_M2	HSALNG0022085	integenic	Q50	NA	-	ATIC	ENSG00000272942
ENSG00000237638	LINC02245	-1.78164178845113	1.07254058859089e-22	M1_vs_M2	HSALNG0015516	integenic	Not conserved	NA	NA	RAB1A	TMTC4
ENSG00000237886	NALT1	-1.97846151386214	0.0136919278170677	M1_vs_M2	HSALNG0075266	integenic	Q75	hsa-miR-3612,hsa-miR-4674,hsa-miR-5088-3p	Sucrose liking measurement,-	EGFL7	PRR19
ENSG00000237927	NA	3.98743536876677	4.12044373131607e-5	M1_vs_M2	HSALNG0054755	integenic	Not conserved	hsa-miR-183-5p,hsa-miR-5585-3p,hsa-miR-6089	Lipoprotein a measurement,Atrophic macular degeneration,-	SOD2	EPB41L5
ENSG00000237943	PRKCQ-AS1	1.36765319339612	0.0120136583912057	M1_vs_M2	HSALNG0075966	integenic	Q50	hsa-miR-30b-3p,hsa-miR-891a-3p,hsa-miR-4632-3p,hsa-miR-6763-5p	Atopic asthma,Eosinophil count,Eczema; Respiratory system disease,Eosinophil percentage of leukocytes,Eczema; Allergic rhinitis,-	PFKFB3	CUTALP
ENSG00000237976	RFX5-AS1	1.86314735978578	0.0394785587478718	M1_vs_M2	HSALNG0007143	anti_sense	Q90	NA	-	PSMB4	AGK
ENSG00000237989	LINC01679	3.29097057196783	0.00652988104739024	M1_vs_M2	HSALNG0133409	integenic	Not conserved	hsa-miR-6842-5p	Agents acting on the renin-angiotensin system use measurement,Diastolic blood pressure; Systolic blood pressure,Diastolic blood pressure,Phosphatidylcholine 38:2 measurement; Phosphatidylcholine 38:3 measurement,Bmi-adjusted waist circumference,Hair color,Systolic blood pressure,Blood pressure; Cardiovascular disease; Chronic obstructive pulmonary disease,Eye color,Cirrhosis of liver; Non-alcoholic fatty liver disease,High density lipoprotein cholesterol measurement; Metabolic syndrome,-	SIK1	ENSG00000270605
ENSG00000238045	MVP-DT	2.74144705430832	6.66103297872311e-34	M1_vs_M2	HSALNG0144898	anti_sense	Q90	hsa-miR-4745-3p	NA	CDIPT	CEBPB
ENSG00000238164	TNFRSF14-AS1	-1.29299907764667	9.191078668932679e-40	M1_vs_M2	HSALNG0000275	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4481,hsa-miR-1343-3p,hsa-miR-5589-5p,hsa-miR-6751-3p,hsa-miR-6769a-3p,hsa-miR-6813-5p,hsa-miR-6852-5p	Eosinophil count,Rheumatoid arthritis,Eosinophil count; Eosinophil percentage of leukocytes,-	HES5	ALDH3B1
ENSG00000239445	ST3GAL6-AS1	-1.78979198289002	1.7781601260136498e-35	M1_vs_M2	HSALNG0027499	anti_sense	Q50	hsa-miR-937-5p	Leukocyte count; Monocyte count,Vascular endothelial growth factor receptor 3 measurement,Monocyte percentage of leukocytes,Eosinophil count,Keratinocyte carcinoma; Basal cell carcinoma,Leukocyte count,Eosinophil count; Skin neoplasm,Eosinophil count; Eosinophil percentage of leukocytes,Unipolar depression,Non-melanoma skin carcinoma,-	DCBLD2	TNFRSF14-AS1
ENSG00000240057	NEPRO-AS1	1.41927833480869	0.0197126757943735	M1_vs_M2	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8	GYG1P3
ENSG00000241042	NA	5.1793029704971	0.0261869570745922	M1_vs_M2	HSALNG0003965	integenic	Not conserved	NA	Excessive daytime sleepiness measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Protein measurement,Intelligence; Verbal-numerical reasoning measurement,Mathematical ability,Fat body mass,Platinum measurement; Response to cisplatin,-	JUN	ENSG00000241042
ENSG00000241886	NA	1.5060607218937	3.87539434452712e-6	M1_vs_M2	HSALNG0137207	sense	Q90	NA	-	GK	PLSCR2
ENSG00000242048	PRKAG2-AS2	2.7719839774696	1.2837438517835602e-67	M1_vs_M2	HSALNG0149841	anti_sense	Not conserved	NA	NA	GALNTL5	SPRED3
ENSG00000242258	LINC00996	8.61396056987221	2.50898569414866e-21	M1_vs_M2	HSALNG0062275	sense	Not conserved	NA	Electroencephalogram measurement	GIMAP8	B3GALNT1
ENSG00000242516	LINC00960	2.7295422838014902	3.17937417022368e-7	M1_vs_M2	HSALNG0026938	anti_sense	Not conserved	hsa-miR-619-5p	NA	FRG2C	KL
ENSG00000242973	TDRD6-AS1	3.43232374417238	0.00247226590320578	M1_vs_M2	HSALNG0050369	anti_sense	Q50	hsa-miR-567,hsa-miR-4447	Hashimoto's thyroiditis; Autoimmune thyroid disease; Graves disease,-	PLA2G7	ADORA3
ENSG00000243055	GK-AS1	1.98568852208356	4.67619327561791e-15	M1_vs_M2	HSALNG0151186	anti_sense	Q50	hsa-miR-619-5p	-	TAB3	MARCHF3
ENSG00000243089	NA	3.92588215776317	2.43690367388509e-8	M1_vs_M2	HSALNG0027523	integenic	Q50	NA	Bmi-adjusted waist circumference; Optic cup area measurement,Serum alanine aminotransferase measurement,Precuneus cortex volume measurement,Optic cup area measurement; Optic disc size measurement,Cup-to-disc ratio measurement,Rr interval,Optic disc area measurement,Liver fibrosis measurement,Susceptibility to childhood ear infection measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Chronic kidney disease,Body height,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,Cup-to-disc ratio measurement; Optic cup area measurement,-	FILIP1L	SRSF12
ENSG00000243491	NA	-3.79146145443008	8.98898574562129e-6	M1_vs_M2	HSALNG0012921	integenic	Not conserved	hsa-miR-665,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-4650-5p,hsa-miR-4691-5p,hsa-miR-6829-5p	NA	YWHAQ	CDC14B
ENSG00000244586	WNT5A-AS1	6.39603895767572	1.4908963961702e-4	M1_vs_M2	HSALNG0147531	anti_sense	Q90	hsa-miR-7108-3p	-	CACNA2D3	LINC03032
ENSG00000245025	NA	1.4574123409357	8.81385312041949e-6	M1_vs_M2	HSALNG0063952	anti_sense	Not conserved	hsa-miR-6805-5p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Renal cell carcinoma,Basal cell carcinoma,-	PEBP4	CD99L2
ENSG00000245248	USP2-AS1	-2.63585016654305	3.54470280008695e-21	M1_vs_M2	HSALNG0143088	integenic	Not conserved	NA	-	RNF26	DGKZ
ENSG00000245552	LNCRNA-IUR	3.01308856116784	8.43370338010721e-7	M1_vs_M2	HSALNG0086562	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-619-5p,hsa-miR-3960	Mean reticulocyte volume; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Red blood cell distribution width,Eosinophil count,Common carotid intimal medial thickness,-	ENDOD1	LINC02846
ENSG00000245573	BDNF-AS	-1.57996756809746	1.22737702552913e-5	M1_vs_M2	HSALNG0083312	integenic	Not conserved	NA	NA	BBOX1	ARV1
ENSG00000245928	SDAD1-AS1	6.93877289151193	5.41039828925783e-7	M1_vs_M2	HSALNG0035291	anti_sense	Not conserved	NA	Lung carcinoma,Blood protein measurement,-	ART3	G0S2
ENSG00000246250	NA	1.6523083150576	0.035363079349589203	M1_vs_M2	HSALNG0083840	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4487	Body mass index,Chronotype measurement,-	ALX4	C1orf35
ENSG00000246528	SLCO5A1-AS1	5.61548484218654	0.00431913636995389	M1_vs_M2	HSALNG0066029	anti_sense	Q50	NA	Leukocyte count; Neutrophil count,Diverticular disease,Response to cetuximab; Skin disease,-	SULF1	NBDY
ENSG00000246640	PICART1	-2.74212429815137	6.5109838147746e-6	M1_vs_M2	HSALNG0117242	anti_sense	Q90	hsa-miR-3178,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-10392-3p	-	SAMD14	LHFPL5
ENSG00000247081	BAALC-AS1	2.85816299272053	1.14376596817179e-5	M1_vs_M2	HSALNG0067506	integenic	Q50	NA	NA	SLC25A32	SPRN
ENSG00000247095	MIR210HG	3.23284615666775	8.32897325810339e-5	M1_vs_M2	HSALNG0081992	anti_sense	Q50	hsa-miR-766-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6735-5p,hsa-miR-6735-3p,hsa-miR-6858-5p,hsa-miR-7843-5p	Systemic lupus erythematosus,High density lipoprotein cholesterol measurement,-	LMNTD2	PUS7
ENSG00000247317	LY6E-DT	3.4828326484895	0.00775851894878751	M1_vs_M2	HSALNG0069213	anti_sense	Not conserved	hsa-miR-6132,hsa-miR-6779-5p,hsa-miR-6784-5p,hsa-miR-6869-3p,hsa-miR-8485	-	LY6S	HNRNPA3
ENSG00000247708	STX18-AS1	-1.1002627597452	3.0257359436750403e-15	M1_vs_M2	HSALNG0032553	integenic	Q50	NA	NA	MSX1	GIMAP7
ENSG00000248187	NA	-4.24355551699876	1.31966162376556e-200	M1_vs_M2	HSALNG0037074	integenic	Q50	hsa-miR-6855-5p,hsa-miR-6769b-5p	NA	PGRMC2	TBC1D8
ENSG00000248323	LUCAT1	1.27596082520106	1.11939631373433e-14	M1_vs_M2	HSALNG0043427	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4270,hsa-miR-4290,hsa-miR-5006-5p,hsa-miR-6089	Melanoma,Cervical carcinoma,Hematocrit,Red blood cell density measurement,Erythrocyte count,Body height,Uric acid measurement; Cystatin c measurement,Lean body mass,Hip geometry,Colorectal health,Adolescent idiopathic scoliosis,Colorectal cancer,-	ARRDC3	ARF6
ENSG00000248538	PPP1R3B-DT	-5.27935225567772	0.0288267710451134	M1_vs_M2	HSALNG0063318	integenic	Q50	hsa-miR-6803-5p	NA	ERI1	THSD7A
ENSG00000248693	LINC02100	3.21576650734255	0.0113113843656151	M1_vs_M2	HSALNG0040483	integenic	Not conserved	NA	NA	CDH18	ENSG00000270966
ENSG00000248809	LINC01095	5.30047479152969	0.0186598852663398	M1_vs_M2	HSALNG0037693	integenic	Q50	hsa-miR-1227-5p,hsa-miR-6802-5p,hsa-miR-6819-5p,hsa-miR-1273h-5p	Systolic blood pressure change measurement; Response to hydrochlorothiazide,Fev/fec ratio; Response to bronchodilator,-	SLC10A7	DKK3
ENSG00000248932	COPB2-DT	-1.29928037408388	4.85150464139845e-5	M1_vs_M2	HSALNG0029337	integenic	Not conserved	hsa-miR-765	NA	MRPS22	PLCB4
ENSG00000249173	LINC01093	5.9380904169547	5.87143561877143e-18	M1_vs_M2	HSALNG0039055	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6808-5p,hsa-miR-6769b-5p	NA	ACSL1	LINC01882
ENSG00000249207	NA	2.61611326086532	0.00995873932984861	M1_vs_M2	HSALNG0033933	integenic	Not conserved	hsa-miR-6090,hsa-miR-1273h-5p	NA	TMEM156	HOMER1
ENSG00000249249	TICAM2-AS1	3.4713271204398	9.54410368816254e-6	M1_vs_M2	HSALNG0044270	anti_sense	Q90	NA	-	AP3S1	ZBTB10
ENSG00000249502	MED28-DT	2.839074092431	2.20179346995167e-33	M1_vs_M2	HSALNG0033145	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4771	-	FAM184B	RHBDD1
ENSG00000249685	NA	1.65000732762558	3.05462479658958e-4	M1_vs_M2	HSALNG0033928	integenic	Q50	NA	Acute lymphoblastic leukemia	KLHL5	CCZ1B
ENSG00000249825	THBS4-AS1	-3.45080151517203	1.85980153471604e-15	M1_vs_M2	HSALNG0042960	anti_sense	Q90	hsa-miR-4447	Corneal topography,Intraocular pressure measurement,-,Thyroid stimulating hormone measurement; Abnormality of refraction	SERINC5	CCDC6
ENSG00000250033	SLC7A11-AS1	4.3699234323679	1.76053962782235e-4	M1_vs_M2	HSALNG0037355	anti_sense	Q75	hsa-miR-6089	Body height,Neuroticism measurement,Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Eosinophil count; Serum metabolite measurement; Depressive symptom measurement; Eosinophil percentage of leukocytes,Eosinophil count,Ccl2 measurement,Wellbeing measurement; Smoking behaviour measurement,-	NOCT	ARHGEF10
ENSG00000250041	NA	-2.62482149872415	9.67328835381323e-29	M1_vs_M2	HSALNG0082662	integenic	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6165	Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	ZBED5	PCBD1
ENSG00000250274	NA	4.28203618510721	1.71616320328339e-14	M1_vs_M2	NA	NA	NA	NA	NA	LCP2	STING1
ENSG00000250519	NA	2.67435454550383	2.01004173523722e-6	M1_vs_M2	HSALNG0086510	integenic	Q50	NA	Serum alanine aminotransferase measurement,-	PANX1	CYBA
ENSG00000250548	LINC01303	3.00612898881332	2.5604956039021e-8	M1_vs_M2	HSALNG0101771	anti_sense	Q75	NA	Susceptibility to vaginal yeast infection measurement,Asthma exacerbation measurement,-	TMEM30B	KIF1B
ENSG00000250777	NA	-1.69831746631007	0.00280692563634116	M1_vs_M2	HSALNG0037343	integenic	Q75	hsa-miR-6825-5p	Parental longevity,Energy intake,Systemic lupus erythematosus,Sleep duration; Triglyceride measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,-	PCDH18	PGF
ENSG00000250802	ZBED3-AS1	-2.72716868214838	2.56645309861793e-28	M1_vs_M2	HSALNG0042820	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6803-5p,hsa-miR-6892-3p	Self-injurious behavior,Fasting blood glucose measurement,Autism,Glucose measurement; Fasting blood glucose measurement,Hemoglobin a1 measurement; Bmi-adjusted waist-hip ratio,Body mass index,Glucose measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Hba1c measurement,Glucose measurement; Hba1c measurement,Hba1c measurement; Bmi-adjusted waist-hip ratio,Dental caries,Testosterone measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Thyroid stimulating hormone measurement; Erythrocyte count,Hematocrit; Hemoglobin measurement; Red blood cell density measurement,Hemoglobin measurement,Bmi-adjusted waist-hip ratio,-	NA	ENTPD4
ENSG00000250929	LINC01181	3.02984479458118	9.160343503708779e-60	M1_vs_M2	HSALNG0067501	integenic	Q50	NA	Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC	TMEM140
ENSG00000251136	RIPK2-DT	2.7282888462863	4.4864625073683e-112	M1_vs_M2	HSALNG0066822	integenic	Q50	NA	Human papilloma virus infection; Oropharynx cancer,-	NBN	ZNFX1
ENSG00000251179	TMEM92-AS1	5.87400247882502	4.28580013462198e-4	M1_vs_M2	HSALNG0117279	anti_sense	Not conserved	hsa-miR-762,hsa-miR-4505,hsa-miR-6813-5p	NA	COL1A1	CCR6
ENSG00000251230	MIR3945HG	5.95444930013549	4.76237926750329e-177	M1_vs_M2	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1	GBP1P1
ENSG00000251301	LINC02384	6.84630315046473	4.13520978780404e-236	M1_vs_M2	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	WARS1
ENSG00000251323	LINC02728	3.15869162162347	1.18872536642734e-7	M1_vs_M2	HSALNG0085981	integenic	Q75	hsa-miR-4530	Creatinine measurement; Body height,Total blood protein measurement	GAB2	KCNK5
ENSG00000251432	LINC02615	-1.34426488015466	0.0321140646623887	M1_vs_M2	HSALNG0037069	integenic	Q50	NA	NA	LARP1B	MIR1286
ENSG00000251586	TET2-AS1	-1.99085009536143	0.0197853177992384	M1_vs_M2	HSALNG0036166	anti_sense	Not conserved	NA	Ulcerative colitis; Intelligence; Body height,Intelligence; Testosterone measurement; Insomnia measurement; Body height; Body weight,Bmi-adjusted waist circumference; Glomerular filtration rate,Heel bone mineral density,Uric acid measurement,Leukocyte count,Forced expiratory volume,Pulse pressure measurement; Bmi-adjusted hip circumference,Self reported educational attainment; Intelligence,Intelligence,Body height,Lifestyle measurement,Colorectal cancer; Household income; Colorectal adenoma,Forced expiratory volume; Chronic obstructive pulmonary disease,Trauma exposure measurement; Primary biliary cirrhosis,Fev/fec ratio; Primary biliary cirrhosis,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lymphocyte percentage of leukocytes; Glomerular filtration rate; Lymphocyte count; Creatinine measurement; Neutrophil percentage of leukocytes,Neutrophil count,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Self reported educational attainment; Intelligence; Risk-taking behaviour; Hemorrhoid,Melanoma,Self reported educational attainment; Intelligence; Mathematical ability,Self reported educational attainment; Intelligence; Birth weight,Age at menarche,Tonsillectomy risk measurement,Attention deficit hyperactivity disorder; Risk-taking behaviour; Antisocial behaviour measurement; Substance abuse,Intelligence; Bmi-adjusted waist-hip ratio,Risk-taking behaviour,Self reported educational attainment,Appendicular lean mass,Platelet count,Prostate carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Risky sexual behaviour measurement,Intelligence; Risk-taking behaviour,Platelet crit,Breast carcinoma,Self reported educational attainment; Intelligence; Mathematical ability; Coffee consumption measurement; Cognitive function measurement,Intelligence; Household income,Intelligence; Lean body mass,Body weight,Neutrophil-to-lymphocyte ratio; Total blood protein measurement; Intelligence; Lymphocyte count,Health study participation,Verbal-numerical reasoning measurement,Myeloid white cell count,Testosterone measurement,Response to vaccine,Household income,Social interaction measurement,Obesity,Wellbeing measurement,Bmi-adjusted hip circumference,Forced expiratory volume; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Nevus count; Cutaneous melanoma,Body height; Pulse pressure measurement; Chronic obstructive pulmonary disease,-,Forced expiratory volume; Birth weight; Chronic obstructive pulmonary disease; Fev/fec ratio; Peak expiratory flow; Smoking status measurement,Coffee consumption measurement; Tea consumption measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Bmi-adjusted waist circumference; Hba1c measurement; Bmi-adjusted waist-hip ratio,Serum non-albumin protein measurement	PPA2	SMIM17
ENSG00000253123	NA	-1.36029109079993	4.49218825912738e-53	M1_vs_M2	HSALNG0064558	integenic	Q90	hsa-miR-4483,hsa-miR-6743-3p,hsa-miR-7150,hsa-miR-8485	-	BRF2	KCNK6
ENSG00000253154	NA	-2.06178262983349	4.40806097035365e-7	M1_vs_M2	HSALNG0066721	integenic	Q50	hsa-miR-4463,hsa-miR-8485	Chronotype measurement,-	ATP6V0D2	B3GALNT2
ENSG00000253217	NA	-1.32482938293879	0.0306143546786907	M1_vs_M2	HSALNG0067281	anti_sense	Q75	NA	Unipolar depression,Lymphocyte count,-	SPAG1	MIA2-AS1
ENSG00000253317	NA	5.41397112355578	0.00463570143048947	M1_vs_M2	HSALNG0066124	integenic	Not conserved	NA	-	KCNB2	DEFB1
ENSG00000253320	MAILR	2.91373664008169	8.336077996457081e-32	M1_vs_M2	HSALNG0067488	integenic	Q50	NA	NA	ATP6V1C1	LINC01010
ENSG00000253351	LINC01298	-7.87673930320987	4.86830523750153e-16	M1_vs_M2	HSALNG0067084	integenic	Q50	hsa-miR-30b-3p,hsa-miR-331-3p,hsa-miR-4308,hsa-miR-5572	Low density lipoprotein cholesterol measurement	CFAP418	ENSG00000259871
ENSG00000253522	MIR3142HG	1.71412063458006	6.922883005763449e-118	M1_vs_M2	HSALNG0046249	integenic	Not conserved	NA	NA	PTTG1	PDCD6IP
ENSG00000253535	ADAM7-AS1	4.75482740013034	3.1783304390425e-9	M1_vs_M2	HSALNG0064058	integenic	Not conserved	NA	NA	NEFL	PLEKHA2
ENSG00000253549	CA3-AS1	-1.54780403503974	1.46600300356701e-4	M1_vs_M2	HSALNG0066709	anti_sense	Q50	hsa-miR-491-5p,hsa-miR-4482-5p,hsa-miR-4707-5p,hsa-miR-6810-5p	Glomerular filtration rate,-	CA1	WBP11
ENSG00000253593	NA	2.95490392956039	0.0268207665578588	M1_vs_M2	HSALNG0068775	integenic	Not conserved	hsa-miR-6873-3p	Response to alcohol	CCN4	ENSG00000256894
ENSG00000253671	NA	-1.12412754392839	1.42818691350185e-4	M1_vs_M2	HSALNG0063682	anti_sense	Q50	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-6867-5p	Body height,Blood protein measurement,Fev change measurement; Response to bronchodilator,-	PCM1	DYNLT2
ENSG00000253738	OTUD6B-AS1	-1.06232295238456	8.50488966404279e-14	M1_vs_M2	HSALNG0066885	anti_sense	Q50	NA	-	PIP4P2	MB21D2
ENSG00000253773	CFAP418-AS1	-3.60347201089096	1.3563999934929698e-23	M1_vs_M2	HSALNG0150259	integenic	Q50	hsa-miR-3960,hsa-miR-6089,hsa-miR-8072	NA	PLEKHF2	CRB2
ENSG00000253837	NA	2.40782368675627	0.0287923861570298	M1_vs_M2	HSALNG0063981	anti_sense	Q50	hsa-miR-4534	-	R3HCC1	DGAT1
ENSG00000253838	NA	7.97541447515675	1.6904319662643998e-78	M1_vs_M2	HSALNG0150187	sense	Q50	NA	-	IDO1	CCM2L
ENSG00000253891	NA	6.86190971017057	1.24807406456176e-6	M1_vs_M2	HSALNG0064035	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4463,hsa-miR-4505,hsa-miR-7106-5p	Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Body height,Ankylosing spondylitis,Cleft palate,Necrotizing enterocolitis,Hair colour measurement,Susceptibility to scarlet fever measurement,White matter integrity,Corneal endothelial cell measurement,Idiopathic dilated cardiomyopathy,Mathematical ability,Age at onset,Nicotine withdrawal symptom count,Pallidum volume,Myopia,Brain volume measurement,Seasonality measurement,Interleukin-6 measurement,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Myocarditis; Response to clozapine,Cingulate cortex measurement; Amyloid-beta measurement,Brain volume measurement; Neuroimaging measurement,-	STC1	RFX2
ENSG00000253924	NA	-4.84021146702419	0.0383853546983813	M1_vs_M2	HSALNG0065257	anti_sense	Q90	NA	NA	NPBWR1	RPH3AL-AS1
ENSG00000253931	LINC02990	-3.98062911700072	1.72589212922973e-11	M1_vs_M2	HSALNG0069286	anti_sense	Q75	hsa-miR-6803-5p,hsa-miR-6769b-5p	Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,-	RHPN1	CKAP5
ENSG00000253939	NA	5.30135292501491	0.00760028800282758	M1_vs_M2	HSALNG0064732	anti_sense	Q50	NA	Blood metabolite measurement	ADAM2	NAV3
ENSG00000254027	LNMICC	-1.6490598278334	4.5412460762297e-6	M1_vs_M2	HSALNG0066560	anti_sense	Not conserved	hsa-miR-3195,hsa-miR-4508	-	PMP2	SLCO2B1
ENSG00000254054	NA	-6.09184051374679	1.38754665763221e-16	M1_vs_M2	HSALNG0063689	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-3194-3p,hsa-miR-4257,hsa-miR-2467-3p	NA	PCM1	GPRC5C
ENSG00000254233	LINC02365	-1.33613531428182	0.0113461192349517	M1_vs_M2	HSALNG0039030	integenic	Not conserved	NA	NA	CASP3	PIGH
ENSG00000254248	NA	-5.26206457438085	0.00337811507407169	M1_vs_M2	HSALNG0067071	anti_sense	Not conserved	hsa-miR-6763-5p	Serum alanine aminotransferase measurement,-	TP53INP1	UNC80
ENSG00000254254	PENK-AS1	5.30108016857918	0.0105467274332663	M1_vs_M2	HSALNG0065478	integenic	Q75	hsa-miR-4296	NA	CHCHD7	NBDY
ENSG00000254287	NA	10.1156607745379	1.99015026274422e-49	M1_vs_M2	HSALNG0150387	anti_sense	Q50	NA	-	ADAM2	ENSG00000233029
ENSG00000254338	MAFA-AS1	-4.63288962113427	6.33842219300293e-10	M1_vs_M2	HSALNG0069286	anti_sense	Q75	hsa-miR-6803-5p,hsa-miR-6769b-5p	Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,-	RHPN1	PABIR2
ENSG00000254419	NA	-1.11629148376445	0.00807202978578868	M1_vs_M2	HSALNG0131276	sense	Not conserved	NA	NA	NPEPL1	TMEM175
ENSG00000254545	NA	-1.55207126566831	0.0401804047459858	M1_vs_M2	HSALNG0002264	anti_sense	Q50	hsa-miR-1237-5p,hsa-miR-4498	-	HCRTR1	MARCHF6
ENSG00000254554	ADM-DT	3.88999819874903	1.0141258490495e-4	M1_vs_M2	HSALNG0082648	integenic	Q50	hsa-miR-6132	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Appendicular lean mass,Total cholesterol measurement,Breast carcinoma,-	SBF2	PDIA4
ENSG00000254654	LINC02685	-6.04754090942816	1.82512398311783e-4	M1_vs_M2	HSALNG0083903	integenic	Q50	hsa-miR-30b-3p	-	TSPAN18	SCT
ENSG00000254703	SENCR	-1.8941392580959	8.54375879786383e-7	M1_vs_M2	HSALNG0088110	intronic_antisense	Q90	hsa-miR-4472,hsa-miR-6803-5p	Platelet count; Platelet crit,Basophil count,-	ETS1	KLHL28
ENSG00000254859	NA	1.40764038791268	0.00560862038743888	M1_vs_M2	HSALNG0150508	integenic	Not conserved	NA	Leukocyte count	ZC3H3	FAF1
ENSG00000254872	LINC02688	-4.9839588772027	3.1978449566064e-7	M1_vs_M2	HSALNG0082072	integenic	Q50	hsa-miR-874-3p,hsa-miR-4463	NA	MUC2	CLPTM1
ENSG00000255026	NA	2.25741008847775	0.00274654479614511	M1_vs_M2	HSALNG0081949	integenic	Not conserved	hsa-miR-615-5p,hsa-miR-766-3p	NA	PGGHG	CERK
ENSG00000255050	NA	2.13482647585694	0.0262954628912285	M1_vs_M2	HSALNG0069297	anti_sense	Q50	hsa-miR-4505,hsa-miR-6744-3p	Interleukin 18 measurement	GSDMD	IFFO1
ENSG00000255135	EMSY-DT	-1.71200280866233	3.9651146393162e-4	M1_vs_M2	HSALNG0085855	anti_sense	Q90	hsa-miR-30c-2-3p,hsa-miR-619-5p	Microglial activation measurement,-	THAP12	ZDHHC20P4
ENSG00000255197	NA	-1.99878613553551	2.17992709025316e-58	M1_vs_M2	HSALNG0143174	anti_sense	Q90	NA	Alcohol consumption measurement	SPI1	PHKA2
ENSG00000255320	NA	-1.22112324652019	0.0164109545854174	M1_vs_M2	HSALNG0084993	anti_sense	Q50	hsa-miR-644a,hsa-miR-4508	-	YIF1A	RAD51B
ENSG00000255363	LINC02757	2.40353238309051	2.48776593553975e-5	M1_vs_M2	HSALNG0085868	integenic	Not conserved	hsa-miR-4710	NA	LRRC32	DGKA
ENSG00000255422	NA	-2.3619514790806	6.419428001827259e-16	M1_vs_M2	HSALNG0087571	anti_sense	Q90	NA	-	PHLDB1	MDK
ENSG00000255443	CD44-AS1	2.25910608631708	1.91144092095969e-4	M1_vs_M2	HSALNG0083610	anti_sense	Q50	NA	-	SLC1A2	FASLG
ENSG00000255521	CD44-DT	2.73410037961638	2.6567527167122e-5	M1_vs_M2	HSALNG0083606	anti_sense	Q50	NA	Response to vitamin,-	SLC1A2	ELL
ENSG00000255571	MIR9-3HG	5.41322253065054	0.00924386337438355	M1_vs_M2	HSALNG0108036	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1228-5p,hsa-miR-3178,hsa-miR-4529-5p,hsa-miR-4667-3p,hsa-miR-4710,hsa-miR-6089,hsa-miR-6736-5p,hsa-miR-6810-3p,hsa-miR-6816-5p,hsa-miR-6826-3p,hsa-miR-6887-3p	White matter microstructure measurement,Cortical surface area measurement; Cigarettes per day measurement,Mathematical ability,Body mass index,Comparative body size at age 10, self-reported,Dental caries; Dentures,-	FANCI	SH2D1A
ENSG00000255801	NA	6.15924697422603	1.27345367165209e-4	M1_vs_M2	HSALNG0089073	integenic	Not conserved	NA	Takayasu arteritis,Response to radiation	CLEC4E	GTF2I
ENSG00000255874	PRECSIT	1.37516204806427	5.14297029959831e-4	M1_vs_M2	HSALNG0141617	integenic	Not conserved	NA	Sitting height ratio	ANKRD10	ARMH3
ENSG00000255921	NA	1.78448497218161	5.52818596704825e-7	M1_vs_M2	HSALNG0089886	anti_sense	Not conserved	hsa-miR-6763-5p,hsa-miR-7847-3p	-	IRAG2	ELL2
ENSG00000256128	LINC00944	2.13703639659631	0.0253604049900648	M1_vs_M2	HSALNG0094965	integenic	Not conserved	NA	Peripheral arterial disease; Traffic air pollution measurement	DHX37	ENSG00000279672
ENSG00000256196	NA	1.78067004683075	0.0468959707272587	M1_vs_M2	HSALNG0084483	anti_sense	Q50	hsa-miR-3155b	Blood protein measurement,-	PRPF19	SGSM3
ENSG00000256262	USP30-AS1	2.82544044134687	1.84142339248571e-50	M1_vs_M2	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP	CLU
ENSG00000256442	NA	4.89898885087484	0.0456286442048216	M1_vs_M2	HSALNG0089163	integenic	Not conserved	hsa-miR-6515-5p	NA	KLRB1	ENSG00000254094
ENSG00000256508	MRGPRF-AS1	-3.33182651280526	5.525689124516649e-40	M1_vs_M2	HSALNG0085291	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4710,hsa-miR-6735-3p,hsa-miR-6792-5p,hsa-miR-6803-5p,hsa-miR-6808-5p,hsa-miR-7108-3p	Reticulocyte count,Hair colour measurement,Mosquito bite reaction size measurement,-	TPCN2	VAT1
ENSG00000256746	MADD-AS1	1.98823900042634	1.70068335917472e-16	M1_vs_M2	HSALNG0084043	intronic_antisense	Q75	hsa-miR-6747-3p	NA	ACP2	RASSF1
ENSG00000256948	NA	1.03902611777674	4.45737353247141e-4	M1_vs_M2	HSALNG0088445	anti_sense	Not conserved	hsa-miR-939-5p	Response to candesartan	SLC6A12	LINC01943
ENSG00000256967	NA	3.64772136135811	4.04038890790375e-12	M1_vs_M2	HSALNG0088974	anti_sense	Q50	hsa-miR-146b-3p	-	RBP5	LINC02015
ENSG00000257027	NA	1.47010053270295	4.6175352357581294e-11	M1_vs_M2	HSALNG0089164	integenic	Not conserved	NA	NA	CLEC2D	FSD1
ENSG00000257127	CLLU1	4.64505594396536	1.68025779971656e-7	M1_vs_M2	HSALNG0093062	anti_sense	Q50	NA	Methionine measurement,Sudden cardiac arrest,-	PLEKHG7	CWF19L2
ENSG00000257354	MIRLET7IHG	1.44875941107065	9.487388834530819e-12	M1_vs_M2	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2	ZFX
ENSG00000257514	NA	-3.53919939334443	0.00559744438557918	M1_vs_M2	HSALNG0093518	anti_sense	Q50	NA	-	SYCP3	LINC00467
ENSG00000257588	AQP5-AS1	-5.44078419579823	0.00515759801137396	M1_vs_M2	HSALNG0090990	anti_sense	Q50	NA	-	RACGAP1	ZNF117
ENSG00000258018	LINC02457	-1.68601615632497	5.00360735480373e-10	M1_vs_M2	HSALNG0094325	integenic	Not conserved	NA	NA	MAP1LC3B2	OGA
ENSG00000258404	LINC02320	-2.43662584817104	3.08832803128537e-4	M1_vs_M2	HSALNG0103850	anti_sense	Q50	hsa-miR-5787	Malate measurement,Balding measurement,Self reported educational attainment,Pulse pressure measurement; Thyroxine measurement,Mathematical ability,Body height,Post-traumatic stress disorder symptom measurement,Eotaxin measurement,Hearing threshold measurement; Hearing measurement,Response to cisplatin; Ovarian carcinoma; Response to paclitaxel; Overall survival,-	HSP90AA1	IGFL2
ENSG00000258441	LINC00641	1.47198488239969	3.25211643804002e-16	M1_vs_M2	HSALNG0099873	integenic	Not conserved	NA	Bipolar disorder,-	HNRNPC	TANC1
ENSG00000258512	LINC00239	-1.84252291841526	3.62306763602056e-4	M1_vs_M2	HSALNG0103853	integenic	Not conserved	hsa-miR-4447	NA	PPP2R5C	ENSG00000286485
ENSG00000258521	NA	2.7928960670848	3.7122085467797e-25	M1_vs_M2	HSALNG0103731	anti_sense	Not conserved	NA	NA	SLC25A47	MTTP
ENSG00000258583	LINC01500	-6.11226740978635	4.3045716574482095e-45	M1_vs_M2	HSALNG0101652	integenic	Not conserved	NA	NA	DACT1	ZNF789
ENSG00000258602	LINC01629	2.56558172429862	1.63747225462996e-10	M1_vs_M2	HSALNG0102605	integenic	Q50	hsa-miR-505-5p,hsa-miR-1268b,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6823-5p,hsa-miR-6858-5p,hsa-miR-6877-3p	Protein measurement,Atrial fibrillation,Total blood protein measurement; Blood protein measurement,-	LRRC74A	CNOT10
ENSG00000258689	LINC01269	-3.45769211427434	3.86837696475207e-9	M1_vs_M2	HSALNG0102232	integenic	Q50	hsa-miR-4309,hsa-miR-4478	-	TTC9	ZNF329
ENSG00000258733	LINC02328	2.05933265942609	2.22010686864589e-8	M1_vs_M2	HSALNG0102968	integenic	Not conserved	NA	NA	FLRT2	MCTP2
ENSG00000258768	NA	-2.19905876312991	0.0018961428828091801	M1_vs_M2	HSALNG0099772	overlap_antisense,anti_sense,sense	Q50	hsa-miR-6809-3p	Cervical carcinoma,Alzheimer's disease biomarker measurement,-	TTC5	UIMC1
ENSG00000258791	LINC00520	-1.65270004762551	8.934430741808929e-19	M1_vs_M2	HSALNG0101489	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6165	Parental longevity,-	TBPL2	ABHD12
ENSG00000258810	NA	-2.26006285570279	5.85653472461775e-5	M1_vs_M2	HSALNG0099831	integenic	Not conserved	hsa-miR-4732-3p	NA	RNASE6	SNORD14A
ENSG00000258875	NA	2.57607516412982	2.27470438358597e-5	M1_vs_M2	HSALNG0103182	anti_sense	Q50	hsa-miR-7155-5p	NA	DGLUCY	CAPRIN2
ENSG00000258919	NA	-1.96083488945976	1.12041973814832e-5	M1_vs_M2	HSALNG0103850	anti_sense	Q50	hsa-miR-5787	Malate measurement,Balding measurement,Self reported educational attainment,Pulse pressure measurement; Thyroxine measurement,Mathematical ability,Body height,Post-traumatic stress disorder symptom measurement,Eotaxin measurement,Hearing threshold measurement; Hearing measurement,Response to cisplatin; Ovarian carcinoma; Response to paclitaxel; Overall survival,-	HSP90AA1	SYS1
ENSG00000259065	MIDEAS-AS1	-2.12051077424385	0.00373322804331551	M1_vs_M2	HSALNG0102380	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4323,hsa-miR-3135b,hsa-miR-4472	-	PTGR2	ENSG00000261245
ENSG00000259094	NA	-5.6182710917517404	5.7735511736177e-4	M1_vs_M2	HSALNG0018295	anti_sense	Not conserved	NA	-	EN1	M1AP
ENSG00000259225	LINC02345	-2.73265200648625	1.12058003245988e-15	M1_vs_M2	HSALNG0105099	integenic	Not conserved	NA	NA	TMCO5A	METTL9
ENSG00000259321	NA	2.26236366046748	0.00324326105959104	M1_vs_M2	HSALNG0100096	anti_sense,sense	Q90	hsa-miR-619-5p	Serum igg glycosylation measurement,-	PSME1	CD99L2
ENSG00000259342	NA	3.23757023540325	1.38006831880634e-13	M1_vs_M2	HSALNG0105649	anti_sense	Q75	hsa-miR-4505	-	GATM	MMP10
ENSG00000259354	NA	4.29396500795143	2.75931767701211e-44	M1_vs_M2	HSALNG0105653	intronic_antisense	Not conserved	NA	NA	C15orf48	SCARA3
ENSG00000259407	NA	4.8990119419897	0.0467264674070517	M1_vs_M2	HSALNG0107883	anti_sense	Q90	hsa-miR-4492,hsa-miR-2467-3p,hsa-miR-7843-5p	Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Eosinophil count,Systolic blood pressure,Eosinophil count; Eosinophil percentage of leukocytes,Alkaline phosphatase measurement,Varicose veins,Idiopathic pulmonary fibrosis,-	KLHL25	KIAA1755
ENSG00000259540	NA	4.89832729069061	0.0322826841724338	M1_vs_M2	HSALNG0108586	anti_sense	Not conserved	NA	-	ASB7	ENSG00000259540
ENSG00000259590	LINC02244	-1.22701707006774	7.065948452348351e-39	M1_vs_M2	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	HAGHL
ENSG00000259668	NA	1.09201730094101	6.07436386609947e-8	M1_vs_M2	HSALNG0105911	anti_sense	Q75	hsa-miR-4443	C-reactive protein measurement,Body mass index,Self reported educational attainment,-,Waist-hip ratio; Smoking behavior; Body mass index,Body fat percentage	GLDN	ARID2
ENSG00000259673	IQCH-AS1	-1.2348887084077	2.31025240801325e-6	M1_vs_M2	HSALNG0106756	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-615-5p,hsa-miR-4478,hsa-miR-6089,hsa-miR-6762-3p,hsa-miR-6849-3p,hsa-miR-6769b-3p,hsa-miR-7703	Serum gamma-glutamyl transferase measurement,Left ventricular diastolic function measurement,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Waist-hip ratio,Bipolar disorder,Bone density,Body mass index,Age at menarche,Erythrocyte count,Body fat percentage,Neuroticism measurement,Response to peginterferon alfa-2a,Risk-taking behaviour,Insomnia measurement,-	AAGAB	CCDC34
ENSG00000259720	NA	-3.41473295353094	0.0239094918692512	M1_vs_M2	HSALNG0144346	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4430	NA	FAN1	ENSG00000286698
ENSG00000259760	NA	-1.20622920986047	5.05137454431877e-27	M1_vs_M2	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	ACAT2
ENSG00000259805	NA	-3.18843898524047	0.0295627693917714	M1_vs_M2	HSALNG0107722	overlap_antisense,overlap_sense,anti_sense	Not conserved	hsa-miR-619-5p	Bmi-adjusted hip circumference,Coronary artery disease,Chronic obstructive pulmonary disease,Mucocutaneous lymph node syndrome,Intelligence,Glomerular filtration rate,Basophil count; Basophil percentage of leukocytes,-	RAMAC	FAM131A
ENSG00000259871	NA	-6.5963623079527	1.35101187434021e-6	M1_vs_M2	HSALNG0109998	sense	Not conserved	hsa-miR-8485	NA	CLEC19A	LINC01298
ENSG00000260077	NA	1.1755160064324	1.1560508963049e-5	M1_vs_M2	HSALNG0012948	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3183	Neuroticism measurement; Worry measurement,Mean corpuscular volume,Body height	CYS1	RGL2
ENSG00000260101	AFTPH-DT	-1.44373926152605	3.24633499800306e-10	M1_vs_M2	HSALNG0015480	anti_sense	Q90	NA	Epithelial cell adhesion molecule measurement,Gut microbiome measurement,-	SERTAD2	SNHG15
ENSG00000260135	MMP2-AS1	2.33775389215887	2.6840710350084e-26	M1_vs_M2	HSALNG0111641	anti_sense	Q90	NA	Abnormality of refraction,Age-related hearing impairment,-	CES1	ABHD17C
ENSG00000260188	NA	-4.13355215686817	4.03663573995751e-4	M1_vs_M2	HSALNG0052706	anti_sense	Q50	hsa-miR-2113,hsa-miR-874-3p,hsa-miR-1268b,hsa-miR-4456,hsa-miR-4778-3p,hsa-miR-6089	Hba1c measurement,Heel bone mineral density,Arachidonic acid measurement,Alpha peak frequency measurement; Electroencephalogram measurement; Alpha wave measurement,-	CDC40	LINC00205
ENSG00000260193	LINC02846	-1.32499028741609	0.00241168099007139	M1_vs_M2	HSALNG0075219	integenic	Q50	hsa-miR-6858-3p	NA	TMEM250	LNCRNA-IUR
ENSG00000260219	CD2BP2-DT	-1.37383553763283	3.7484829721330594e-30	M1_vs_M2	HSALNG0110725	anti_sense	Q50	hsa-miR-4534,hsa-miR-6775-3p	-	MYL11	CRYZ
ENSG00000260256	NA	2.81803232068326	2.93765628183414e-9	M1_vs_M2	HSALNG0133530	integenic	Not conserved	hsa-miR-1178-5p	-	CFAP410	PDIA3
ENSG00000260260	SNHG19	-1.1100564122523	0.0213791148043343	M1_vs_M2	HSALNG0108990	anti_sense	Q50	NA	-	PKD1	RALGAPB
ENSG00000260302	LINC01882	5.7931769351816	0.0010621696202475	M1_vs_M2	HSALNG0120126	integenic	Not conserved	hsa-miR-149-3p,hsa-miR-1268b,hsa-miR-4441,hsa-miR-8485	Interleukin 9 measurement; Macrophage inflammatory protein 1a measurement,Red blood cell density measurement,Psoriasis,Autoimmune disease; Celiac disease,Juvenile idiopathic arthritis,Sarcoidosis,Alopecia areata,-	PTPN2	SCARA3
ENSG00000260351	NA	-2.46185100571198	3.51746944311084e-5	M1_vs_M2	HSALNG0144425	integenic	Q75	NA	NA	TM6SF1	ENSG00000291063
ENSG00000260528	FAM157C	3.46736764652677	3.62578155962003e-4	M1_vs_M2	HSALNG0113696	integenic	Not conserved	hsa-let-7g-3p	-	GAS8	SHISAL1
ENSG00000260542	NA	-2.25568543637153	0.00190041995840177	M1_vs_M2	HSALNG0131538	integenic	Not conserved	NA	NA	GATA5	PYHIN1
ENSG00000260565	ERVK13-1	-1.02712606127401	2.35101513808398e-21	M1_vs_M2	HSALNG0109047	anti_sense	Q75	hsa-miR-4323,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6089	Intraocular pressure measurement,Aspartate aminotransferase measurement,-	PRSS27	PRKX
ENSG00000260630	SNAI3-AS1	-1.43014990151797	5.96520577339659e-10	M1_vs_M2	HSALNG0113528	anti_sense	Q50	hsa-miR-665,hsa-miR-3195,hsa-miR-6089	Airway imaging measurement,Hair colour measurement,Reticulocyte count; Reticulocyte measurement,-	CTU2	APH1A
ENSG00000260661	NA	5.04509024583282	0.0385470395440171	M1_vs_M2	HSALNG0144613	anti_sense	Q75	NA	Diastolic blood pressure,3-hydroxy-1-methylpropylmercapturic acid measurement,Self reported educational attainment,Susceptibility to chronic sinus infection measurement,Dna methylation,Seasonal gut microbiome measurement,Parahippocampal gyrus volume measurement,Smoking initiation,Oral cleft; Alcohol consumption measurement,Colorectal cancer; Diet measurement,Serum dimethylarginine measurement,-	FAM174B	BACH2
ENSG00000260711	NA	2.94656200348685	0.0448916760880063	M1_vs_M2	HSALNG0103215	sense	Not conserved	NA	NA	CATSPERB	FITM1
ENSG00000260751	NA	1.97028304032948	0.0225339043471257	M1_vs_M2	HSALNG0110262	sense	Not conserved	hsa-miR-619-5p	NA	UBFD1	GOSR1
ENSG00000260803	NA	-2.42946115047691	8.79650119999823e-4	M1_vs_M2	HSALNG0144829	integenic	Q75	hsa-miR-4650-5p	-	POLR3K	HMCN1
ENSG00000260804	LINC01963	-1.83930441487498	8.116447854071731e-9	M1_vs_M2	HSALNG0022112	integenic	Q50	NA	NA	XRCC5	TM4SF19-DYNLT2B
ENSG00000260807	CEROX1	-1.71844912996912	1.17176065210457e-13	M1_vs_M2	HSALNG0108830	sense	Q50	hsa-miR-505-5p,hsa-miR-615-5p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-7106-3p,hsa-miR-7160-3p	Body height,-	LMF1	HGSNAT
ENSG00000260877	NA	3.1019523794385	9.05736875615946e-16	M1_vs_M2	HSALNG0085333	integenic	Not conserved	hsa-miR-4308,hsa-miR-4447,hsa-miR-4492	NA	MYEOV	TRAF2
ENSG00000260898	ADPGK-AS1	-1.38461147147263	7.350164341650449e-11	M1_vs_M2	HSALNG0107094	anti_sense	Q75	hsa-miR-484,hsa-miR-6089,hsa-miR-6848-5p,hsa-miR-8485	Urate measurement,Grip strength measurement,Body weight,Vital capacity,Body mass index,Body mass index; Visceral adipose tissue measurement,Triglyceride measurement; Body mass index,-	BBS4	ST3GAL6
ENSG00000260941	LINC00622	-1.2673452196962	0.00858992636024346	M1_vs_M2	HSALNG0006500	integenic	Not conserved	NA	NA	ZNF697	MSMO1
ENSG00000260943	LINC02555	2.40784634860953	0.0288579186054062	M1_vs_M2	HSALNG0090479	integenic	Q50	NA	Inflammatory bowel disease,Low density lipoprotein cholesterol measurement,Mean platelet volume; Platelet count,Bacteriemia,-	SLC2A13	RANBP9
ENSG00000260997	NA	6.71908928603581	2.44430139260509e-144	M1_vs_M2	NA	NA	NA	NA	NA	MYO1G	GBP3
ENSG00000261036	NA	-2.18335075402948	0.00254126128520865	M1_vs_M2	HSALNG0044432	integenic	Not conserved	NA	NA	DTWD2	ASB14
ENSG00000261094	NA	1.66643221094964	2.62748753273707e-4	M1_vs_M2	HSALNG0074265	integenic	Q50	NA	Birth weight; Neuroimaging measurement; Brain volume measurement,-	RABGAP1	BEND3P2
ENSG00000261211	NA	-2.08231668355877	7.05167525007264e-10	M1_vs_M2	HSALNG0047833	integenic	Q75	hsa-miR-6833-3p	Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,-	F13A1	HMGCR
ENSG00000261373	VPS9D1-AS1	1.45228103120746	0.00488836535877472	M1_vs_M2	HSALNG0141629	anti_sense	Q50	hsa-miR-149-3p,hsa-miR-4732-3p,hsa-miR-6808-5p	Blood protein measurement,Hair colour measurement,-	ZNF276	TOM1L1
ENSG00000261596	NA	1.20164375726264	2.58344300946875e-12	M1_vs_M2	HSALNG0110129	sense	Q75	NA	-	METTL9	EPHB2
ENSG00000261618	LINC02605	5.66212823092804	6.03690177131592e-38	M1_vs_M2	HSALNG0150243	integenic	Not conserved	NA	Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A	ASS1
ENSG00000261625	NA	-2.6412517303662	0.0012863927347423	M1_vs_M2	HSALNG0085289	integenic	Not conserved	NA	NA	MRGPRF	NDUFAF3
ENSG00000261644	CYLD-AS1	2.07890429931541	1.20011303005302e-17	M1_vs_M2	HSALNG0111361	anti_sense	Q50	hsa-miR-6089,hsa-miR-8485	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SNX20	PLEKHG2
ENSG00000261888	NA	-3.956436998328	4.38600767612757e-26	M1_vs_M2	HSALNG0145190	integenic	Not conserved	NA	Hematocrit	METRNL	CMTM7
ENSG00000261971	MMP25-AS1	4.04039224309094	3.53619911921394e-59	M1_vs_M2	HSALNG0109107	anti_sense	Q75	hsa-miR-455-3p,hsa-miR-619-5p,hsa-miR-3178,hsa-miR-4286,hsa-miR-4472,hsa-miR-4498,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6132,hsa-miR-6767-5p,hsa-miR-6779-5p,hsa-miR-6803-5p,hsa-miR-6836-5p,hsa-miR-6860,hsa-miR-8072	-	BICDL2	PRDM4
ENSG00000262001	DLGAP1-AS2	1.36208379166697	0.0495254314058128	M1_vs_M2	HSALNG0119714	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4481,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089,hsa-miR-7111-5p,hsa-miR-7150	Mean corpuscular volume,Mean reticulocyte volume,Blood urea nitrogen measurement; Serum urea measurement,Fat body mass,Mean reticulocyte volume; Mean corpuscular volume,Lip morphology measurement,Alanine measurement; Amino acid measurement,-	TGIF1	MTUS1-DT
ENSG00000262097	LINC02185	-4.39283369118713	4.72334777790711e-57	M1_vs_M2	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN	SRGAP3
ENSG00000262151	NA	-4.81698783129593	7.48588734860335e-8	M1_vs_M2	HSALNG0109562	anti_sense	Q50	hsa-miR-149-5p,hsa-miR-619-5p,hsa-miR-4463,hsa-miR-4774-5p,hsa-miR-6728-3p	Red blood cell density measurement; Erythrocyte count,Susceptibility to chronic sinus infection measurement,Nasopharyngeal neoplasm; Bmi-adjusted waist-hip ratio; Celiac disease,Ulcerative colitis,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Monocyte count,Monocyte percentage of leukocytes; Monocyte count,Serum albumin measurement,-	DEXI	NOL4L
ENSG00000262468	LINC01569	1.12147890533883	4.45778436420142e-6	M1_vs_M2	HSALNG0109218	integenic	Q50	hsa-miR-1233-5p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-1273h-5p	Pulse pressure measurement; Central corneal thickness,Electrocardiography; Alkaline phosphatase measurement; Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell density measurement,Red blood cell density measurement; Erythrocyte count,Pulse pressure measurement,Alkaline phosphatase measurement,Mean reticulocyte volume	SRL	VKORC1L1
ENSG00000263050	DPH1-AS1	2.31522315619761	0.0103100689083506	M1_vs_M2	HSALNG0113878	anti_sense	Q75	hsa-miR-3178,hsa-miR-4640-3p,hsa-miR-4747-5p,hsa-miR-8485	Hepatocyte growth factor measurement,-	SMG6	MOB3C
ENSG00000263069	RNF213-AS1	2.00799364254267	1.54249984906211e-16	M1_vs_M2	HSALNG0119191	anti_sense	Q50	NA	-	NPTX1	PLEKHA3
ENSG00000263120	NA	2.13483021599505	0.0261942690803572	M1_vs_M2	HSALNG0117612	sense	Not conserved	NA	-	SCPEP1	TSEN15
ENSG00000263164	NA	-3.18853746467003	0.0295499820323475	M1_vs_M2	HSALNG0114111	anti_sense,sense	Not conserved	NA	Head and neck squamous cell carcinoma,Family history of alzheimer’s disease,Sex hormone-binding globulin measurement,Leukocyte count,Red blood cell density measurement,-	SCIMP	ESPNL
ENSG00000263345	SGSM2-AS1	-1.05027094622258	0.00879411016033555	M1_vs_M2	HSALNG0113905	anti_sense	Q75	hsa-miR-4313,hsa-miR-6132	Self reported educational attainment; Autism spectrum disorder,Lifestyle measurement,-,Household income	MNT	MICU2
ENSG00000263718	SEPTIN9-DT	-1.55588337277128	0.00140515534782739	M1_vs_M2	HSALNG0118918	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-8485	Virologic response measurement; Response to abacavir,-	SRSF2	ENSG00000273145
ENSG00000264290	NA	-1.70615891708996	0.00805785320413863	M1_vs_M2	HSALNG0115587	sense	Q75	hsa-miR-6775-3p	-	TP53I13	RALBP1P1
ENSG00000264456	NA	1.20701135332599	2.60947596244614e-5	M1_vs_M2	HSALNG0115675	intronic_sense	Not conserved	hsa-miR-6089	NA	RNF135	RBBP4
ENSG00000264707	L3MBTL4-AS1	-1.28095635203178	3.57323719180167e-5	M1_vs_M2	HSALNG0119795	anti_sense	Q50	NA	NA	ARHGAP28	ZNF273
ENSG00000265205	NA	2.20054237267111	0.0190526146175291	M1_vs_M2	HSALNG0115495	anti_sense	Q90	hsa-miR-331-3p,hsa-miR-6089	-	SDF2	P4HTM
ENSG00000265479	DTX2P1-UPK3BP1-PMS2P11	5.17897338734385	0.0158458661004797	M1_vs_M2	HSALNG0059099	anti_sense,sense	Q75	NA	Body mass index,Waist-hip ratio; Body mass index,Urinary nitrogen measurement,Response to drug,Macrovascular complications of diabetes; Diabetic eye disease,Comparative body size at age 10, self-reported,Platinum measurement; Response to cisplatin,Interleukin-6 measurement,-	CCDC146	DTX2P1-UPK3BP1-PMS2P11
ENSG00000265678	NA	2.5114029641495	0.00360545372007167	M1_vs_M2	HSALNG0119378	anti_sense	Q50	NA	NA	SLC16A3	ANKRD49P1
ENSG00000266049	NA	-1.39865037863596	0.0152091965371062	M1_vs_M2	HSALNG0119656	anti_sense	Not conserved	hsa-miR-6089	Fat body mass,Nicotine withdrawal symptom count,Mathematical ability,Body height,Response to radiation,-,Conotruncal heart malformations	LPIN2	MAF1
ENSG00000266402	SNHG25	-2.41239267692943	0.00238513018378687	M1_vs_M2	HSALNG0118080	anti_sense	Q75	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6716-5p	-	PRR29	ARHGEF12
ENSG00000266708	NA	5.04591501111578	0.0302802616454767	M1_vs_M2	HSALNG0119876	anti_sense	Q75	NA	-	PPP4R1	NR1D2
ENSG00000266709	NA	4.63790425515448	3.5715443162259996e-37	M1_vs_M2	HSALNG0114719	intronic_sense	Q50	NA	NA	HS3ST3B1	PLTP
ENSG00000266718	NA	-2.69869965586413	0.0450043934545623	M1_vs_M2	HSALNG0115789	anti_sense	Not conserved	NA	Nicotine dependence symptom count	CDK5R1	CNIH1
ENSG00000266835	GAPLINC	-2.83668416713054	1.40991749415172e-44	M1_vs_M2	HSALNG0119710	sense	Not conserved	NA	Pr interval,Citrulline measurement,-	TGIF1	ZSCAN16-AS1
ENSG00000267026	NA	-2.01411416122639	0.00369560986909807	M1_vs_M2	HSALNG0073203	anti_sense	Not conserved	hsa-miR-6729-3p	NA	ANKS6	SLC4A7
ENSG00000267074	NA	2.57511413937494	3.55045616455409e-5	M1_vs_M2	HSALNG0115953	sense	Not conserved	NA	Macrophage inflammatory protein 1b measurement	SLFN12L	ENSG00000233785
ENSG00000267130	NA	-3.54290377119038	0.00528286205162453	M1_vs_M2	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG	PARD3B
ENSG00000267197	NA	3.74582674371951	0.00228100338851806	M1_vs_M2	HSALNG0123939	sense	Not conserved	NA	NA	KEAP1	ENSG00000284734
ENSG00000267272	LINC01140	-1.0875510460034	0.0261869570745922	M1_vs_M2	HSALNG0004949	sense	Q90	NA	Smoking behavior,Cortical surface area measurement,-	NA	CRELD1
ENSG00000267288	NA	5.17784510844847	0.0320127798366342	M1_vs_M2	HSALNG0116825	anti_sense	Q90	hsa-miR-939-3p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-6802-5p	Balding measurement,-	PLCD3	FGFR4
ENSG00000267296	CEBPA-DT	-2.02195516930529	6.001859741796749e-20	M1_vs_M2	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG	FXN
ENSG00000267397	NA	-2.11849247621846	0.0471336847700869	M1_vs_M2	HSALNG0120911	integenic	Not conserved	NA	NA	GALNT1	SSC5D
ENSG00000267452	LINC02073	-2.94368924879377	9.11510994156388e-7	M1_vs_M2	HSALNG0117381	integenic	Not conserved	NA	NA	UTP18	LINC01500
ENSG00000267481	NA	-1.38545286075458	0.0161388232032498	M1_vs_M2	HSALNG0124757	sense	Not conserved	hsa-miR-619-5p	-	ZNF506	FLOT1
ENSG00000267519	MIR23AHG	1.17491332521033	3.2225197904476698e-31	M1_vs_M2	HSALNG0124251	anti_sense	Q90	NA	Waist-hip ratio,Neutrophil-to-lymphocyte ratio; Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Leukocyte count; Lymphocyte count; Myeloid white cell count,Leukocyte count; Lymphocyte count,Lymphocyte count,Fev/fec ratio; Monocyte count,Leukocyte count,Myeloid white cell count; Lymphocyte count,Cortical thickness,-	BRME1	CDK7
ENSG00000267549	ZSCAN5A-AS1	-1.88415225501503	0.00184754882729313	M1_vs_M2	HSALNG0127749	anti_sense	Not conserved	NA	-	EDDM13	DDX55
ENSG00000267712	LINC01539	6.77892073532587	7.16247631783152e-6	M1_vs_M2	HSALNG0121712	integenic	Q75	hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-7108-3p	Risk-taking behaviour,Risky sexual behaviour measurement,Smoking status measurement,Smoking initiation,Smoking behavior; Smoking status measurement,Diabetic retinopathy,Self reported educational attainment; Mathematical ability,Diverticular disease,Unipolar depression,Hiv-1 infection,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Smoking behaviour measurement,-	TCF4	FCAMR
ENSG00000267737	NA	4.02954577886147	1.06849830536531e-8	M1_vs_M2	HSALNG0119029	integenic	Not conserved	NA	NA	PGS1	GATA2
ENSG00000267745	NA	2.95668503819183	0.00354817643638075	M1_vs_M2	HSALNG0115943	integenic	Not conserved	NA	-	SLFN12	SYT15
ENSG00000267751	BSG-AS1	-1.98261010180827	1.03413143968005e-6	M1_vs_M2	HSALNG0122891	integenic	Not conserved	NA	NA	POLRMT	BCAN-AS1
ENSG00000268355	NA	-1.69464325862898	0.0365887631072	M1_vs_M2	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	ZNF775
ENSG00000268895	A1BG-AS1	1.12901510590066	5.25940817481309e-8	M1_vs_M2	HSALNG0127948	anti_sense	Not conserved	hsa-miR-1204,hsa-miR-4505,hsa-miR-4535,hsa-miR-4695-5p,hsa-miR-4707-5p,hsa-miR-6081	-	ZSCAN22	KCTD17
ENSG00000269072	NA	-2.23168782738318	0.0201783089194615	M1_vs_M2	HSALNG0127186	anti_sense	Not conserved	hsa-miR-4463	Sialic acid-binding ig-like lectin 9 measurement,Blood protein measurement; Alkaline phosphatase measurement,Cortical thickness,Blood protein measurement,Granulocyte percentage of myeloid white cells; Blood protein measurement; Cerebrospinal fluid biomarker measurement; Monocyte percentage of leukocytes,Blood protein measurement; Reticulocyte measurement; Cerebrospinal fluid biomarker measurement,C-reactive protein measurement; Body mass index; Protein measurement; Sialic acid-binding ig-like lectin 9 measurement; Blood protein measurement,-	CTU1	COMMD4
ENSG00000269220	LINC00528	2.36774286200846	2.52738686373066e-6	M1_vs_M2	HSALNG0133922	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-4257,hsa-miR-6089,hsa-miR-6877-3p	Response to diisocyanate,Adiponectin measurement	BCL2L13	C11orf16
ENSG00000269293	ZSCAN16-AS1	-1.07379378806882	2.92914033226683e-8	M1_vs_M2	HSALNG0048933	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3972,hsa-miR-7150	NA	OR2B8P	PTX3
ENSG00000269446	NA	-1.37735121362337	1.86547895462806e-5	M1_vs_M2	HSALNG0062712	integenic	Not conserved	NA	NA	UBE3C	ERLIN2
ENSG00000269553	NA	-2.80746207133163	3.26049178137702e-5	M1_vs_M2	HSALNG0125598	intronic_sense	Not conserved	NA	NA	CD22	UBXN10
ENSG00000269667	NA	5.04555505218404	0.0225322712507612	M1_vs_M2	HSALNG0144810	integenic	Not conserved	hsa-miR-4516	Monocyte count,Leukocyte count; Rheumatoid arthritis; Monocyte percentage of leukocytes,Neutrophil count; Granulocyte percentage of myeloid white cells; Myeloid white cell count; Leukocyte count; Monocyte count; Monocyte percentage of leukocytes,Oral ulcer,Eosinophil count,Leukocyte count; Lymphocyte count	IRF8	LGALS14
ENSG00000269889	NA	5.17810122249366	0.0237891739670062	M1_vs_M2	HSALNG0030592	anti_sense	Q50	hsa-miR-941,hsa-miR-6816-5p	Sex hormone-binding globulin measurement; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil percentage of granulocytes; Eosinophil count; Basophil count,Eosinophil count; Eosinophil percentage of leukocytes,Lung adenocarcinoma,Neutrophil percentage of leukocytes,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Platelet count; Erythrocyte count,-	MYNN	IER3IP1
ENSG00000269959	SPACA6-AS1	5.18004575613646	0.0230224587030735	M1_vs_M2	HSALNG0127249	anti_sense	Q75	NA	Calcium measurement,Body height,-	HAS1	FOXD4L1
ENSG00000269970	NA	-1.76281002724624	7.09770518172677e-4	M1_vs_M2	HSALNG0074238	sense	Not conserved	NA	NA	PTGS1	CDK19
ENSG00000269982	NA	-1.21559565606203	4.04509691447849e-6	M1_vs_M2	HSALNG0024078	anti_sense	Q50	NA	Blood protein measurement,-	CRELD1	IFNAR1
ENSG00000270120	NA	3.70235891616784	6.42868862122572e-7	M1_vs_M2	HSALNG0111360	sense	Q50	NA	NA	NOD2	TNPO2
ENSG00000270164	LINC01480	-3.65740991510332	1.9903257018319e-60	M1_vs_M2	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	HOMER2
ENSG00000270426	NA	1.0008219631903	0.00871129987798866	M1_vs_M2	HSALNG0039018	sense	Q90	NA	NA	IRF2	GPR171
ENSG00000270605	NA	1.65567382375248	0.00259091621689785	M1_vs_M2	HSALNG0002045	anti_sense	Q50	hsa-miR-19b-2-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-5693,hsa-miR-5787,hsa-miR-6089	Aspartate aminotransferase measurement,-	DNAJC8	LINC01679
ENSG00000270607	NAV2-AS6	1.76175888093274	4.06679155050834e-4	M1_vs_M2	HSALNG0083062	anti_sense	Q75	NA	-	DBX1	EXOC4
ENSG00000271032	NA	3.41816086154375	3.83302958368093e-21	M1_vs_M2	HSALNG0125561	anti_sense	Not conserved	NA	Calcium measurement; Serum albumin measurement,Serum albumin measurement,-	ZNF792	PIM3
ENSG00000271040	TMEM242-DT	-2.55447430253591	0.00318813990218286	M1_vs_M2	HSALNG0054615	anti_sense	Not conserved	NA	-	ZDHHC14	P2RY12
ENSG00000271086	NAMA	-3.22368974069556	0.00245642763452072	M1_vs_M2	HSALNG0073233	integenic	Q75	hsa-miR-892b,hsa-miR-4279,hsa-miR-4638-3p,hsa-miR-5001-3p,hsa-miR-5589-5p,hsa-miR-6504-5p,hsa-miR-6830-5p,hsa-miR-8485	Callous-unemotional behaviour; Body mass index,Mathematical ability,-	ALG2	RB1CC1
ENSG00000271474	UNC5C-AS1	6.02389975717956	4.58677045933554e-4	M1_vs_M2	HSALNG0035909	anti_sense	Q50	NA	-	PDHA2	ART3
ENSG00000271643	PDCD6IP-DT	1.45579249034848	4.52705837057481e-9	M1_vs_M2	HSALNG0025078	anti_sense	Not conserved	NA	-	CLASP2	TICAM2-AS1
ENSG00000271880	NA	-1.66694445253194	0.00129273383029153	M1_vs_M2	NA	NA	NA	NA	NA	ADIRF	TRPV2
ENSG00000271926	NA	-2.83123089231283	2.2243678219725504e-9	M1_vs_M2	HSALNG0042600	anti_sense	Q75	hsa-miR-4466,hsa-miR-3960	Serum urea measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Calcium measurement,Heel bone mineral density,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Monocyte count,Mean reticulocyte volume; Mean corpuscular volume; Serum albumin measurement,-	ZNF366	PRRC1
ENSG00000271931	PNRC1-DT	6.15903442421242	1.53545553975256e-4	M1_vs_M2	HSALNG0051848	integenic	Q50	hsa-miR-4492,hsa-miR-6803-5p,hsa-miR-6810-3p	Sleep duration	SRSF12	LGALS14
ENSG00000271952	LINC01954	-2.60027480951726	0.00700383038045878	M1_vs_M2	HSALNG0146022	overlap_sense	Not conserved	NA	Childhood aggressive behaviour measurement,Chronotype measurement,Exploratory eye movement measurement,Neuropsychological test,Mathematical ability,Fev/fec ratio; Response to bronchodilator,-	KCNF1	PIGZ
ENSG00000272008	NA	5.87400747005344	8.68790863729428e-4	M1_vs_M2	HSALNG0149464	anti_sense	Q75	NA	-	CGA	PLEKHA2
ENSG00000272068	BCAN-AS1	-1.94519148742913	1.39001869371475e-4	M1_vs_M2	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	BSG-AS1
ENSG00000272079	NA	-1.49963334996586	0.00894717101113768	M1_vs_M2	HSALNG0109099	integenic	Q50	hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6089,hsa-miR-6784-5p,hsa-miR-6813-5p,hsa-miR-8072	-	NA	ZFP57
ENSG00000272081	FCHO2-DT	-2.81899642656908	2.07973543385042e-22	M1_vs_M2	HSALNG0042600	anti_sense	Q75	hsa-miR-4466,hsa-miR-3960	Serum urea measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Calcium measurement,Heel bone mineral density,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Monocyte count,Mean reticulocyte volume; Mean corpuscular volume; Serum albumin measurement,-	ZNF366	DMWD
ENSG00000272129	NA	-2.67284284759742	0.0197072159722544	M1_vs_M2	HSALNG0051481	integenic	Q50	NA	NA	BCKDHB	ZNF223
ENSG00000272145	NFYC-AS1	1.64367676740203	0.0169328737274068	M1_vs_M2	HSALNG0002891	anti_sense	Q90	hsa-miR-661,hsa-miR-4447,hsa-miR-4761-3p,hsa-miR-8072	Body height,-	RIMS3	ENSG00000285632
ENSG00000272172	NA	-2.77443260802493	0.0452306899807258	M1_vs_M2	HSALNG0069270	anti_sense	Not conserved	hsa-miR-3960	Body height,-	TOP1MT	CLPP
ENSG00000272269	NUP153-AS1	1.47334197010183	0.00667200329961769	M1_vs_M2	HSALNG0048366	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6769b-5p	-	FAM8A1	ARMT1
ENSG00000272335	NA	-1.17167650600416	1.02367009636099e-6	M1_vs_M2	HSALNG0041565	integenic	Not conserved	NA	-	MRPS30	TTC3
ENSG00000272338	NA	-1.78843428022585	0.0318905130270974	M1_vs_M2	HSALNG0064463	integenic	Not conserved	NA	NA	FUT10	CYP2S1
ENSG00000272341	NA	-2.19572022565434	9.02202241130302e-16	M1_vs_M2	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	SIGLEC6
ENSG00000272405	NA	-1.27189936362994	3.18660639855749e-11	M1_vs_M2	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	TSPO
ENSG00000272449	NA	1.1087814453684	3.3640931221077196e-11	M1_vs_M2	HSALNG0000274	integenic	Not conserved	hsa-miR-8485	NA	TNFRSF14	PEA15
ENSG00000272463	NA	2.54140178150777	5.03603172987918e-4	M1_vs_M2	HSALNG0047304	integenic	Q50	NA	-	EXOC2	IRF5
ENSG00000272482	NA	-4.78872233010798	0.0228891006928291	M1_vs_M2	HSALNG0000950	integenic	Q90	hsa-miR-6756-5p	NA	DHRS3	EEF1A1P44
ENSG00000272555	NA	-1.06301546790336	0.0143890716317161	M1_vs_M2	HSALNG0022299	integenic	Not conserved	NA	NA	CYP27A1	RPL7P50
ENSG00000272666	KLHDC7B-DT	4.87236292407263	1.06119533697767e-14	M1_vs_M2	HSALNG0136305	integenic	Q50	hsa-miR-5589-5p	Erythrocyte count,Monocyte count	SYCE3	EDARADD
ENSG00000272669	NA	1.51601984232817	3.6780362218521e-4	M1_vs_M2	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p	NA	GTPBP1	SPOCK2
ENSG00000272734	ADIRF-AS1	-1.35216984556787	7.15829336603827e-12	M1_vs_M2	HSALNG0079425	anti_sense,sense	Q75	hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-4505,hsa-miR-1587	-	MMRN2	TGIF1
ENSG00000272768	NA	-1.09660107154823	0.0163236676270664	M1_vs_M2	HSALNG0057688	anti_sense	Q50	hsa-miR-1301-3p,hsa-miR-1237-5p,hsa-miR-3960,hsa-miR-5691	Platelet count,Aging,Reaction time measurement,Reticulocyte count,-	PPIA	ENSG00000230747
ENSG00000272839	NA	-1.56060006364701	0.00167215001772399	M1_vs_M2	HSALNG0062763	anti_sense	Not conserved	hsa-miR-4463	NA	DNAJB6	KRT10
ENSG00000272894	MIOS-DT	1.85715778498648	0.00705105571043999	M1_vs_M2	HSALNG0056056	anti_sense	Not conserved	hsa-miR-5571-3p	NA	COL28A1	USP53
ENSG00000272941	NA	1.16102711095535	3.43660123557461e-4	M1_vs_M2	HSALNG0061535	anti_sense	Q50	NA	-	TMEM140	PSMA3-AS1
ENSG00000272986	NA	5.0444675089177196	0.0465571543514727	M1_vs_M2	HSALNG0035038	anti_sense	Q50	NA	NA	JCHAIN	MILR1
ENSG00000273002	ARHGEF2-AS2	1.52495106810236	3.5007231362967403e-9	M1_vs_M2	HSALNG0007540	anti_sense	Q75	NA	Comparative body size at age 10, self-reported,-	RXFP4	CHD9NB
ENSG00000273032	DGCR5	-5.77037740089222	1.02519766442118e-15	M1_vs_M2	HSALNG0133984	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-764	NA	FAM246C	SH2B2
ENSG00000273143	DUSP5-DT	-1.01781116594848	0.0341719283614438	M1_vs_M2	HSALNG0080582	integenic	Q50	NA	Heel bone mineral density,Bone density,-	SMNDC1	CX3CR1
ENSG00000273145	NA	-1.00824369366683	0.0176138637050674	M1_vs_M2	HSALNG0135987	sense	Not conserved	hsa-miR-3622b-3p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-6132,hsa-miR-6803-5p,hsa-miR-6870-5p,hsa-miR-10394-5p	Risk-taking behaviour; Smoking status measurement,Body height,Dupuytren contracture,Unipolar depression,Birth weight,Wellbeing measurement; Dupuytren contracture,Alcohol use disorder measurement; Alcohol consumption measurement,Body weight,Body height; Body weight,Smoking status measurement,Ovarian carcinoma,Sex hormone-binding globulin measurement,Chemokine (c-c motif) ligand 27 measurement,Protein measurement,Electroencephalogram measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Alkaline phosphatase measurement; Igf-1 measurement,Triglyceride measurement,Behavioural disinhibition measurement,Eosinophil count; Bmi-adjusted hip circumference; Body height; Eosinophil percentage of leukocytes,-,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder	PPARA	SEPTIN9-DT
ENSG00000273179	NA	-1.59680494962047	0.00749048280335255	M1_vs_M2	HSALNG0032247	anti_sense	Not conserved	hsa-miR-23a-5p	NA	MAEA	SLC2A9
ENSG00000273226	NA	-3.05239926722305	4.6700275286185106e-9	M1_vs_M2	HSALNG0070293	anti_sense	Not conserved	NA	NA	DENND4C	UBA1
ENSG00000273272	NA	5.04556035608985	0.0377318558828679	M1_vs_M2	HSALNG0147331	integenic	Not conserved	NA	Monocyte count	KLHDC7B	ZNF319
ENSG00000273314	NA	2.73057382907904	2.24763859251862e-6	M1_vs_M2	HSALNG0062087	anti_sense	Q50	hsa-miR-668-5p	NA	EZH2	PDLIM2
ENSG00000273341	NA	-1.62487181282166	4.03799685501861e-11	M1_vs_M2	HSALNG0059115	anti_sense	Q50	hsa-miR-4466,hsa-miR-7703	Body mass index,Gut microbiome measurement,Hba1c measurement,Hemoglobin a1 measurement,-	CCDC146	EXOC5
ENSG00000273387	NA	-3.03199875083343	3.6502687723071e-6	M1_vs_M2	HSALNG0134940	anti_sense	Q75	hsa-miR-762,hsa-miR-4447,hsa-miR-4505,hsa-miR-6735-5p	Fev/fec ratio,-	SELENOM	PPP6R3
ENSG00000273472	NA	2.54099565618252	4.63690857062953e-39	M1_vs_M2	HSALNG0148201	integenic	Q50	NA	NA	ELMOD2	PIM3
ENSG00000273824	NA	6.78982136621153	1.96537247887647e-32	M1_vs_M2	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	UPK3B
ENSG00000273828	NA	1.64216052528015	0.00174774546159031	M1_vs_M2	HSALNG0130476	anti_sense	Q50	NA	-	CD40	BTBD8
ENSG00000273855	NA	-1.30171725292475	1.95049394037303e-4	M1_vs_M2	HSALNG0105214	sense	Q75	hsa-miR-4293,hsa-miR-5088-3p	NA	PLCB2	GTPBP3
ENSG00000273972	NA	2.12648372705159	0.00871129987798866	M1_vs_M2	HSALNG0105662	integenic	Not conserved	NA	-	SQOR	ENSG00000225200
ENSG00000274020	LINC01138	1.82293385114646	1.65577497154484e-8	M1_vs_M2	HSALNG0006866	integenic	Not conserved	NA	NA	PPIAL4G	CD72
ENSG00000274265	NA	2.85392026057059	0.00227048778394135	M1_vs_M2	HSALNG0141909	integenic	Not conserved	hsa-miR-885-3p	-	PDE4DIP	DOCK9
ENSG00000274370	NA	-2.37820187164058	9.16039309718131e-6	M1_vs_M2	HSALNG0119502	integenic	Not conserved	hsa-miR-6784-5p	NA	METRNL	ABCC10
ENSG00000274422	NA	-2.43428823769151	2.77980929225425e-5	M1_vs_M2	HSALNG0134310	integenic	Not conserved	hsa-miR-6132,hsa-miR-8072	-	ZNF280B	ENSG00000226862
ENSG00000274461	LINC02930	-4.59090640950499	3.05448299885243e-39	M1_vs_M2	HSALNG0081109	integenic	Not conserved	NA	Adolescent idiopathic scoliosis,Left inferior lateral ventricle volume measurement; T-tau measurement; Cerebrospinal fluid biomarker measurement,-	PLPP4	MID1IP1
ENSG00000274508	NA	2.31692298566083	8.03897375902585e-5	M1_vs_M2	HSALNG0111641	anti_sense	Q90	NA	Abnormality of refraction,Age-related hearing impairment,-	CES1	ITIH2
ENSG00000274515	NA	5.41396893672735	0.00459291914054856	M1_vs_M2	HSALNG0107305	intronic_antisense	Q50	hsa-miR-6787-3p	NA	SNX33	AMN
ENSG00000274536	MIR223HG	-1.87086877526325	5.09993587941724e-5	M1_vs_M2	HSALNG0138297	anti_sense	Q50	hsa-miR-331-3p	Balding measurement,Eosinophil count,Alopecia,Mean platelet volume; Platelet count,Eosinophil percentage of leukocytes	HEPH	LINS1
ENSG00000274565	NA	-3.00128798307644	2.35294279441003e-4	M1_vs_M2	HSALNG0117970	anti_sense	Q75	NA	-	MARCHF10	FBXW2
ENSG00000275120	NA	-2.03445764098231	0.032697185764862	M1_vs_M2	HSALNG0107802	integenic	Not conserved	NA	NA	WDR73	RANBP6
ENSG00000275180	NA	1.38987414254836	9.55415420771018e-6	M1_vs_M2	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2	TRPM2-AS
ENSG00000275278	NA	-3.51822853513702	0.0107155364666618	M1_vs_M2	HSALNG0090086	anti_sense	Q50	hsa-miR-3960,hsa-miR-6744-3p,hsa-miR-4433b-3p	Fructose measurement; Glucose measurement; Galactose measurement,-	ERGIC2	SIGLEC9
ENSG00000275431	NA	5.30112641193916	0.00941708549613526	M1_vs_M2	HSALNG0115994	anti_sense	Q50	NA	Blood protein measurement,Eyelid sagging measurement,C-c motif chemokine 15 measurement	CCL18	ACOD1
ENSG00000276148	NA	-1.92443771802251	0.0460222855392904	M1_vs_M2	HSALNG0090284	anti_sense	Q75	NA	NA	YARS2	PPP2R2D
ENSG00000276248	NA	-1.06733314074017	0.0421208028091153	M1_vs_M2	HSALNG0099603	sense	Not conserved	NA	NA	TMCO3	BICRAL
ENSG00000276462	LINC03025	7.83634483713895	2.2824410417833803e-74	M1_vs_M2	HSALNG0071581	integenic	Not conserved	NA	NA	FOXD4L6	LGALS14
ENSG00000276476	LINC00540	4.72624479461621	5.4899476095992e-9	M1_vs_M2	HSALNG0143794	integenic	Q50	NA	NA	FGF9	NOTCH4
ENSG00000277007	NA	-4.07982463813376	3.2817510092606e-4	M1_vs_M2	HSALNG0010635	sense	Q75	NA	Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Fev/fec ratio; Heel bone mineral density,Erythrocyte count,Chronic obstructive pulmonary disease,Fev/fec ratio,Gut microbiome measurement,Pulse pressure measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Lean body mass,Hematocrit,-	LYPLAL1	ZPR1
ENSG00000277089	CCL3-AS1	-3.99431083223149	1.46085342764663e-39	M1_vs_M2	HSALNG0116003	anti_sense,sense	Q75	hsa-miR-604,hsa-miR-4726-5p,hsa-miR-6077,hsa-miR-6089,hsa-miR-6743-5p	Blood protein measurement,C-c motif chemokine 3 measurement	CCL18	MAOA
ENSG00000277287	NA	-1.24149159976855	0.0024866643068662702	M1_vs_M2	HSALNG0128242	integenic	Not conserved	NA	-	ITPA	AP1M1
ENSG00000277425	NA	5.04524734057416	0.0277384080948533	M1_vs_M2	HSALNG0128363	sense	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	-	TMEM230	DCAF1
ENSG00000278112	NA	-3.12760259057355	0.0028870972839459	M1_vs_M2	HSALNG0094744	sense	Q50	hsa-miR-204-3p,hsa-miR-4508,hsa-miR-4722-5p	NA	RILPL1	ENSG00000276248
ENSG00000278330	NA	-1.38841556242335	2.90038805100301e-6	M1_vs_M2	HSALNG0122607	anti_sense	Not conserved	NA	-	GALR1	WDR33
ENSG00000278869	NA	1.2601503078691	0.0142998382159468	M1_vs_M2	HSALNG0136238	anti_sense	Q90	hsa-miR-874-3p,hsa-miR-4447,hsa-miR-4463,hsa-miR-1343-5p,hsa-miR-5088-3p,hsa-miR-6799-5p,hsa-miR-6877-3p	-	ALG12	EOLA2
ENSG00000279277	NA	1.18478746612044	6.43886896211218e-4	M1_vs_M2	HSALNG0027881	integenic	Q50	hsa-miR-5787	Bipolar disorder,-	CD47	MAN1B1-DT
ENSG00000279278	NA	-2.29596931456871	7.914191994453549e-19	M1_vs_M2	HSALNG0134311	integenic	Not conserved	hsa-miR-198,hsa-miR-210-5p	NA	VPREB1	MIR600HG
ENSG00000279833	NA	-1.3796648401208	0.0092354292246273	M1_vs_M2	NA	NA	NA	NA	NA	APOBEC3H	ENSG00000259094
ENSG00000280832	GSEC	2.13817875046145	3.34284731486147e-7	M1_vs_M2	HSALNG0088026	anti_sense	Q50	NA	Neutrophil count,Low density lipoprotein cholesterol measurement,-	KIRREL3	SPOCD1
ENSG00000281005	LINC00921	-1.79926840436863	4.99234574233874e-7	M1_vs_M2	HSALNG0109143	sense	Not conserved	hsa-miR-3925-3p	NA	NA	PARP3
ENSG00000281103	TRG-AS1	1.31278750846584	6.94186210338095e-39	M1_vs_M2	HSALNG0057335	integenic	Not conserved	NA	NA	STARD3NL	SLC2A1
ENSG00000281392	LINC00506	3.3629532152516	0.0037085712721025	M1_vs_M2	HSALNG0027226	integenic	Not conserved	NA	Prostate carcinoma,-	CHMP2B	NPDC1
ENSG00000281756	C2-AS1	2.37241919328189	0.00940331461124481	M1_vs_M2	HSALNG0049350	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492	Age-related macular degeneration,Von willebrand factor measurement,Bmi-adjusted waist circumference; Autism spectrum disorder,Blood protein measurement,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,-	NELFE	GJD3
ENSG00000281920	NA	-6.1766313879602	1.3791679374911e-4	M1_vs_M2	HSALNG0015543	integenic	Q90	hsa-miR-128-2-5p,hsa-miR-194-3p,hsa-miR-619-5p,hsa-miR-3190-5p,hsa-miR-4258,hsa-miR-4447,hsa-miR-4685-3p,hsa-miR-4763-3p,hsa-miR-6130,hsa-miR-6132,hsa-miR-6730-5p,hsa-miR-6752-3p,hsa-miR-6858-5p	Systemic lupus erythematosus,Neutrophil percentage of leukocytes,Crohn's disease; Inflammatory bowel disease,Lymphocyte percentage of leukocytes; Myeloid white cell count; Granulocyte count,Monocyte percentage of leukocytes; Monocyte count,Bell's palsy,Body height; Bipolar disorder,Bipolar disorder,Body height,Pulse pressure measurement,Systolic blood pressure,Waist-hip ratio,Protein measurement,Iron biomarker measurement,Nicotine dependence symptom count,Cognitive decline measurement,Neuroimaging measurement,Fev/fec ratio,Brain volume measurement,Isthmus cingulate cortex volume measurement,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Cortical surface area measurement,Cortical surface area measurement; Cortical thickness,Facial morphology measurement; Gut microbiome measurement,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Serum gamma-glutamyl transferase measurement; Vital capacity,White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio; Smoking behavior; Bmi-adjusted waist-hip ratio,Calcium measurement,Sex hormone-binding globulin measurement,Susceptibility to chickenpox measurement,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Myocardial infarction,Heel bone mineral density,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Electroencephalogram measurement; Theta wave measurement,Squamous cell lung carcinoma; Family history of lung cancer,Covid-19; Mortality,Forced expiratory volume; Response to bronchodilator,Post-operative delirium; Response to surgery,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement,Bipolar disorder; Body mass index,Response to ketamine; Dissociation measurement,-	ACTR2	SLC9A3-AS1
ENSG00000282164	PEG13	-2.72086491926145	0.0266886447905643	M1_vs_M2	HSALNG0150502	sense	Not conserved	NA	NA	TRAPPC9	SORCS2
ENSG00000282221	NA	5.30245257657712	0.0170681931602151	M1_vs_M2	HSALNG0009643	anti_sense	Q50	hsa-miR-23b-5p,hsa-miR-615-5p	-	PKP1	CALY
ENSG00000282572	FAM157D	1.75285540462317	0.0152961616392704	M1_vs_M2	HSALNG0055481	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	-	PDGFA	GJB6
ENSG00000282851	BISPR	1.10037479618708	2.98224878946894e-13	M1_vs_M2	HSALNG0124521	sense	Not conserved	hsa-miR-6775-3p	Blood phosphate measurement,-	MVB12A	ZFP36
ENSG00000283213	NA	-1.6231576820473	7.12897939712191e-4	M1_vs_M2	HSALNG0110217	anti_sense	Q90	NA	-	USP31	IFT88
ENSG00000283633	NA	-1.37876948953949	2.71129838671488e-6	M1_vs_M2	HSALNG0133812	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6784-5p	-	IL17RA	LGALS8
ENSG00000283648	NA	7.01298790192912	2.61368401280679e-7	M1_vs_M2	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2	ENSG00000289173
ENSG00000284240	LINC02801	-2.5898603381432	0.0206332564808583	M1_vs_M2	HSALNG0004954	integenic	Q90	hsa-miR-619-5p,hsa-miR-5587-3p,hsa-miR-6085	Eosinophil count,Loneliness measurement,Basophil count,Basophil percentage of granulocytes; Basophil count; Basophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Basophil count,Eosinophil count; Eosinophil percentage of leukocytes,Insomnia measurement,-	NA	MAPK3
ENSG00000284428	NA	-1.1936627626235	0.0394278929763586	M1_vs_M2	HSALNG0125033	sense	Not conserved	hsa-miR-30b-3p,hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-632,hsa-miR-4318,hsa-miR-1268b,hsa-miR-4673,hsa-miR-4722-5p,hsa-miR-6075	Lysophosphatidylcholine 20:3 measurement,Hyperuricemia; Gout,Forced expiratory volume; Smoking status measurement,Pain measurement; Response to non-steroidal anti-inflammatory,-	NA	APPBP2-DT
ENSG00000284543	LINC01226	-3.2064322183894	0.0387427781601752	M1_vs_M2	HSALNG0002236	sense	Q75	hsa-miR-1231,hsa-miR-1207-5p,hsa-miR-4434	Intelligence,-	TINAGL1	PRKDC
ENSG00000284633	NA	3.48201493256992	8.01860485493371e-13	M1_vs_M2	HSALNG0135492	anti_sense	Q50	hsa-miR-4463,hsa-miR-4776-5p,hsa-miR-6769b-5p	Fev/fec ratio,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Body weight,Platelet crit,Biliary liver cirrhosis,Hair colour measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SYNGR1	DLG1
ENSG00000284669	NA	1.89910494953009	0.00509355551564156	M1_vs_M2	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A	GRSF1
ENSG00000284722	NA	-3.68529841842698	0.00269302581388352	M1_vs_M2	NA	NA	NA	NA	NA	OR2AT4	SLC24A1
ENSG00000284734	NA	5.18004652463669	0.0230392942212518	M1_vs_M2	HSALNG0005052	anti_sense	Not conserved	NA	NA	GBP6	ENSG00000267197
ENSG00000284882	NA	-1.00087453517078	6.32952451986415e-6	M1_vs_M2	HSALNG0004813	anti_sense	Q50	NA	-	SPATA1	C9orf72
ENSG00000285190	NA	-6.14713470923443	3.91417482786033e-5	M1_vs_M2	HSALNG0043300	anti_sense	Q50	hsa-miR-7703	Body mass index,Body height,-	RASA1	SMAD6
ENSG00000285239	NA	5.41321374963741	0.00935315046818663	M1_vs_M2	HSALNG0142409	anti_sense	Not conserved	NA	NA	CD34	ENSG00000289530
ENSG00000285533	RELA-DT	-1.09272866590374	6.35407460258203e-4	M1_vs_M2	HSALNG0084930	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-762,hsa-miR-665,hsa-miR-4508,hsa-miR-6086	Urate measurement,Heel bone mineral density,Platelet count,-	SIPA1	H2BC4
ENSG00000285551	LINC02929	-4.6747982554284	4.22328249835187e-7	M1_vs_M2	HSALNG0078329	sense	Q75	hsa-miR-4505,hsa-miR-1587,hsa-miR-5703	NA	NA	SP2
ENSG00000285632	NA	-1.90343267080144	0.031032781780874	M1_vs_M2	HSALNG0064623	anti_sense	Not conserved	hsa-miR-619-5p	-	PLPP5	TMEM120A
ENSG00000285736	NA	-3.518262790503	0.0107096837906049	M1_vs_M2	HSALNG0045746	anti_sense	Not conserved	NA	-	IL17B	HSPB1P2
ENSG00000285744	NA	5.77294761188865	4.442086500384449e-141	M1_vs_M2	HSALNG0066417	integenic	Not conserved	NA	NA	ZC2HC1A	WARS1
ENSG00000285761	NA	2.23308237765466	3.60457957765828e-6	M1_vs_M2	HSALNG0049090	integenic	Not conserved	hsa-miR-6085	Crohn's disease,Small cell lung carcinoma,Sleep duration,Lymphocyte count,Bmi-adjusted waist-hip ratio,-	HLA-F	ZNF416
ENSG00000285863	NA	1.1652267028654	0.0113024351058241	M1_vs_M2	HSALNG0144382	anti_sense	Not conserved	NA	Fev/fec ratio,-	C2CD4A	ENSG00000289261
ENSG00000285907	NA	4.52055721311827	1.21033045850263e-7	M1_vs_M2	HSALNG0072614	integenic	Q50	hsa-miR-619-5p,hsa-miR-4455,hsa-miR-6826-3p	Body mass index; Metabolic syndrome,Risk-taking behaviour,Triglyceride measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Triglyceride measurement; Aspartate aminotransferase measurement,Grip strength measurement; Body mass index,Visceral adipose tissue measurement,Body mass index,Chronotype measurement,Fibrinogen measurement; Cortical thickness,Cleft lip; Cleft palate,Serum alanine aminotransferase measurement; Response to combination chemotherapy,Triglyceride measurement; Chronotype measurement,Neuroimaging measurement; Brain measurement,Age at menarche,Cortical surface area measurement; Hemoglobin measurement; Hematocrit; Mathematical ability,Hematocrit,Cognitive function measurement,Mathematical ability,-	SEMA4D	C16orf87
ENSG00000285966	NA	3.31884322735943	4.35716576745612e-5	M1_vs_M2	HSALNG0102615	integenic	Q50	hsa-miR-1268b,hsa-miR-4463,hsa-miR-4667-3p	-	IRF2BPL	LY96
ENSG00000286004	NA	1.56127683919582	0.00109227186289724	M1_vs_M2	HSALNG0031856	anti_sense	Not conserved	NA	Creatinine measurement; Glomerular filtration rate,-	MUC20	ENSG00000262482
ENSG00000286062	NA	-1.18681394880938	1.17986515736525e-5	M1_vs_M2	HSALNG0042332	integenic	Q75	hsa-miR-508-5p	Sepsis; Mortality,Systolic blood pressure,-	SGTB	DDIAS
ENSG00000286067	NA	1.4744972357624	6.36870065962435e-14	M1_vs_M2	HSALNG0094501	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-6791-5p	NA	SIRT4	RIGI
ENSG00000286129	NA	-1.32268526036654	0.00553718019098196	M1_vs_M2	HSALNG0134321	integenic	Not conserved	NA	-	VPREB1	NME6
ENSG00000286162	NA	2.44889241069814	1.55585225848431e-24	M1_vs_M2	HSALNG0069800	integenic	Q50	NA	NA	PLGRKT	JAK2
ENSG00000286174	NA	5.08934753503033	1.13558671638302e-28	M1_vs_M2	HSALNG0010970	anti_sense	Q50	NA	Mortality,White matter microstructure measurement,-	WDR26	RAP2C
ENSG00000286176	NA	-3.12789699227147	0.00286076524881281	M1_vs_M2	HSALNG0032624	anti_sense	Not conserved	NA	High density lipoprotein cholesterol measurement,Drugs used in diabetes use measurement,Glucose measurement,Hba1c measurement,-,Cholesteryl ester 16:0 measurement,Longevity	PPP2R2C	PIK3CB
ENSG00000286248	NA	1.17715034348267	0.00526251991639604	M1_vs_M2	HSALNG0094569	anti_sense	Not conserved	hsa-miR-1268b	Interleukin-8 measurement; C-reactive protein measurement; Chronic obstructive pulmonary disease,C-reactive protein measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,-	CAMKK2	ENSG00000247903
ENSG00000286276	NA	1.42175023148393	0.00775938946128959	M1_vs_M2	HSALNG0006333	integenic	Q50	hsa-miR-615-5p,hsa-miR-4519	Diastolic blood pressure,Cystatin c measurement,Leukocyte count; Neutrophil count,Creatinine measurement,Systemic lupus erythematosus,Stressful life event measurement; Depressive symptom measurement,-	ATP1A1	GSE1
ENSG00000286481	NA	-3.82114773753689	9.16811328018417e-13	M1_vs_M2	HSALNG0018495	integenic	Not conserved	NA	NA	TSN	TMEM106B
ENSG00000286504	NA	6.02389341035047	4.47959338001683e-4	M1_vs_M2	HSALNG0089056	integenic	Not conserved	NA	NA	FAM90A1	ZNF132
ENSG00000286546	NA	-3.24198165992301	7.288264265949759e-20	M1_vs_M2	HSALNG0128824	anti_sense	Not conserved	NA	Cognitive impairment measurement,High density lipoprotein cholesterol measurement; Response to diuretic,-	KIF16B	PYGL
ENSG00000286548	NA	2.36280869418998	1.34932702506087e-10	M1_vs_M2	HSALNG0005059	anti_sense	Q50	NA	Prostate carcinoma,Blood protein measurement,Total blood protein measurement,Mathematical ability,Adolescent idiopathic scoliosis,Bilirubin measurement,-	GBP5	TRIM26
ENSG00000286558	NA	2.18836481459991	0.00313744824299057	M1_vs_M2	HSALNG0148220	integenic	Not conserved	NA	-	TMEM144	TOMM20P2
ENSG00000286646	MAP3K5-AS2	-3.64903303949979	8.79621926857372e-85	M1_vs_M2	HSALNG0053719	anti_sense	Q50	hsa-miR-619-5p	NA	PEX7	RIN3
ENSG00000286696	NA	-1.30210744696218	0.0192987964239778	M1_vs_M2	HSALNG0144397	anti_sense	Q75	NA	NA	CCDC33	FKBP9
ENSG00000286698	NA	-5.50708261812002	0.00382301273461299	M1_vs_M2	HSALNG0016845	integenic	Not conserved	NA	NA	EIF2AK3	RFX4
ENSG00000286707	NA	-3.24205919998749	0.0010798845565807	M1_vs_M2	HSALNG0013717	anti_sense,sense	Q90	NA	Non-small cell lung carcinoma,-	SELENOI	PIK3C2B
ENSG00000286757	NA	-1.21774882297667	0.0207207785054935	M1_vs_M2	HSALNG0098950	integenic	Q75	hsa-miR-6730-3p	Sleep measurement,-	ZIC5	ACADM
ENSG00000286872	NA	-2.74274693326781	4.862642126611609e-50	M1_vs_M2	HSALNG0107736	integenic	Not conserved	hsa-miR-4447,hsa-miR-4505	NA	HDGFL3	PAK1
ENSG00000286972	NA	-3.40275091180709	1.4510822842783202e-14	M1_vs_M2	HSALNG0146843	integenic	Q90	NA	Abnormal paneth cell measurement,-	TOP1	JDP2
ENSG00000287024	NA	-2.59966954151986	0.012390572048676	M1_vs_M2	HSALNG0140088	integenic	Q75	hsa-miR-3960,hsa-miR-6724-5p,hsa-miR-6773-5p	NA	APLN	UROS
ENSG00000287074	NA	-2.35530690494019	0.0415181616528055	M1_vs_M2	HSALNG0143356	sense	Not conserved	NA	NA	AEBP2	GORAB
ENSG00000287091	NA	-1.53423933461537	0.014492198842819	M1_vs_M2	HSALNG0146641	sense	Q50	hsa-miR-1203	NA	CD302	TSC22D1
ENSG00000287123	NA	-3.59631409175752	2.76016473164672e-4	M1_vs_M2	HSALNG0146118	integenic	Q50	hsa-miR-619-5p,hsa-miR-4437,hsa-miR-6124,hsa-miR-6813-5p	-	SLC1A4	ZMYND11
ENSG00000287245	NA	-1.88140431800494	0.01764278023295369	M1_vs_M2	HSALNG0087038	anti_sense	Not conserved	NA	NA	ZC3H12C	CCDC88A
ENSG00000287255	NA	-2.72928357930875	6.645418541489e-4	M1_vs_M2	HSALNG0014389	anti_sense	Q50	hsa-miR-619-5p	Qt interval; Pr interval,Qt interval,Pr interval,Protein measurement,Qt interval; Tpe interval measurement,Electrocardiography,Bone fracture,Dna methylation,Heel bone mineral density,Forced expiratory volume; Response to bronchodilator,-	TMEM178A	RBP1
ENSG00000287263	NA	1.99397201073078	2.6770626206462797e-60	M1_vs_M2	HSALNG0041483	integenic	Not conserved	hsa-miR-6807-3p	Intelligence,Cytokine measurement	ANXA2R	C1RL
ENSG00000287265	NA	1.47428959083945	0.00118392997229436	M1_vs_M2	HSALNG0047279	integenic	Not conserved	NA	NA	EXOC2	FUS
ENSG00000287335	NA	5.41370382193243	0.00625696095437759	M1_vs_M2	HSALNG0130592	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Seasonality measurement,-	NCOA3	ENSG00000287335
ENSG00000287415	NA	-4.59769516171447	8.957048105462539e-16	M1_vs_M2	HSALNG0025355	integenic	Q50	hsa-miR-8485	Polyp of colon,Colorectal cancer; Colorectal adenoma,Colorectal cancer,Heel bone mineral density,Hip bone mineral density,Testosterone measurement; Systolic blood pressure,Testosterone measurement,Hypermetropia; Bone density; Myopia,Bone density,Femoral neck bone mineral density; Bone fracture,Bone density; Heel bone mineral density,Drugs affecting bone structure and mineralization use measurement,Femoral neck bone mineral density; Spine bone mineral density,Osteoporosis,Lean body mass; Bone density,Adolescent idiopathic scoliosis,Systolic blood pressure,Myopia,Mean arterial pressure,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Response to amisulpride; Longitudinal bmi measurement,Refractive error,-	ZNF621	LCA5L
ENSG00000287494	NA	-1.34742467590051	0.0062000240503538	M1_vs_M2	HSALNG0144545	anti_sense	Q50	hsa-miR-5787	Fev/fec ratio,Platelet component distribution width	PIF1	MTATP6P1
ENSG00000287497	NA	-2.71925340247823	2.4929965461781e-6	M1_vs_M2	HSALNG0047831	integenic	Q75	hsa-miR-151a-5p,hsa-miR-151b,hsa-miR-4710	Serum alanine aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,Mean reticulocyte volume; Mean corpuscular volume; Erythrocyte count,Mean corpuscular volume,Monocyte count,Pelvic organ prolapse,Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Urate measurement,-	LY86	TIGAR
ENSG00000287543	NA	3.81830261497137	1.867220611805e-17	M1_vs_M2	HSALNG0144564	anti_sense	Q50	NA	Bmi-adjusted hip circumference,-	GOLGA6A	ENSG00000254287
ENSG00000287576	NA	2.45791394136315	9.221425802522569e-11	M1_vs_M2	HSALNG0150312	integenic	Not conserved	NA	Leukocyte count	GSDMD	NRG2
ENSG00000287691	NA	2.48548065028536	7.20501612485849e-5	M1_vs_M2	HSALNG0002358	anti_sense	Q50	hsa-miR-4448	Mosaic loss of chromosome y measurement,-	HPCA	FTX
ENSG00000287733	NA	1.00676557391682	3.48426934656037e-6	M1_vs_M2	HSALNG0061536	integenic	Not conserved	hsa-miR-4761-3p	Monocyte count	TMEM140	SLC25A34
ENSG00000287736	PTCSC1	-1.20920543876302	0.0128400415883277	M1_vs_M2	HSALNG0068717	anti_sense,sense	Not conserved	NA	Eosinophil percentage of leukocytes	TG	KLHDC8B
ENSG00000287771	NA	-5.2922937918169	0.00526097145195595	M1_vs_M2	HSALNG0017397	integenic	Q50	NA	Ulcerative colitis; Crohn's disease,Autism spectrum disorder; Ulcerative colitis; Ankylosing spondylitis; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder,-	IL1R1	ADAMTSL2
ENSG00000287778	NA	-2.05181882884444	6.20288106602492e-7	M1_vs_M2	HSALNG0032926	integenic	Not conserved	NA	NA	DRD5	ACTG1
ENSG00000287809	NA	-2.79296866925362	0.0095608176082632	M1_vs_M2	HSALNG0110117	anti_sense,sense	Not conserved	NA	Velopharyngeal dysfunction,Adolescent idiopathic scoliosis,Empathy measurement,Unipolar depression,Major depressive disorder; Unipolar depression,Balding measurement,Inflammatory biomarker measurement; Ykl40 measurement,Bipolar disorder; Unipolar depression; Disease recurrence,Thrombin activatable fibrinolysis inhibitor activation peptide measurement,-	METTL9	ENSG00000289080
ENSG00000287839	NA	2.06698735376776	2.3589154247481e-19	M1_vs_M2	HSALNG0007520	integenic	Not conserved	NA	Neutrophil count	YY1AP1	COG5
ENSG00000287893	NA	-3.65765485556375	0.00655240831549467	M1_vs_M2	HSALNG0057241	integenic	Not conserved	NA	-	HERPUD2	LINC02925
ENSG00000287917	NA	1.24714122409334	0.00409468735343839	M1_vs_M2	HSALNG0084879	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3620-3p,hsa-miR-6089,hsa-miR-6803-5p	-	SLC25A45	ENSG00000288748
ENSG00000287978	NA	-2.15302179711757	0.0165877701109464	M1_vs_M2	HSALNG0141895	integenic	Not conserved	NA	NA	POLR3GL	GZMK
ENSG00000288066	NA	-1.01580585776538	7.83493816928054e-4	M1_vs_M2	HSALNG0019641	anti_sense	Q90	NA	-	RIF1	MT-RNR2
ENSG00000288700	NA	-3.23952755893023	3.83809595838149e-12	M1_vs_M2	HSALNG0147628	intronic_sense	Q50	NA	NA	CEP63	VLDLR
ENSG00000288743	NA	-2.01412460766129	0.00860304141549667	M1_vs_M2	HSALNG0097024	overlap_antisense,anti_sense	Q50	hsa-miR-4480,hsa-miR-6747-5p,hsa-miR-7155-5p	Uterine fibroid,-	CAB39L	TRA2A
ENSG00000288754	NA	-1.9005373348942	2.02387078510583e-7	M1_vs_M2	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4	YOD1
ENSG00000288767	NA	4.18719210760918	7.416060185590041e-10	M1_vs_M2	HSALNG0096284	integenic	Not conserved	NA	NA	RFC3	PTGES3P1
ENSG00000288819	NA	2.46531850180915	0.00335774784041231	M1_vs_M2	NA	NA	NA	NA	NA	CATIP	ZNF554
ENSG00000288919	NA	3.3464299116294	0.017634499785243	M1_vs_M2	HSALNG0126003	integenic	Q75	hsa-miR-1237-5p,hsa-miR-4492,hsa-miR-6803-3p	-	MED29	THYN1
ENSG00000288927	NA	-2.18297671746798	0.00513072692639575	M1_vs_M2	HSALNG0000949	anti_sense	Q90	NA	-	AADACL4	MIR3667HG
ENSG00000288928	NA	-2.01411812576329	0.00342762553735481	M1_vs_M2	NA	NA	NA	NA	NA	HIF1A	CCSAP
ENSG00000288954	NA	8.70536262988487	2.23594520315044e-22	M1_vs_M2	HSALNG0089060	integenic	Not conserved	hsa-miR-211-3p	Blood protein measurement,-	CLEC4E	FNBP4
ENSG00000288961	NA	1.53356443254705	6.57721208698525e-6	M1_vs_M2	HSALNG0116727	integenic	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-4508,hsa-miR-6816-5p	-	RUNDC3A	M1AP
ENSG00000289015	NA	-1.00260045532239	0.0444568551435736	M1_vs_M2	HSALNG0058614	anti_sense	Not conserved	NA	-	SBDS	ASB14
ENSG00000289053	NA	3.15228149529626	2.18437914743461e-4	M1_vs_M2	HSALNG0056798	integenic	Q50	NA	Interleukin 18 measurement,Gestational age,Monocyte percentage of leukocytes,-	NFE2L3	DCAF11
ENSG00000289070	NA	-4.30151756467478	5.55212555689536e-31	M1_vs_M2	HSALNG0118660	anti_sense	Q50	hsa-miR-619-5p	Blood protein measurement,-	CD300A	LY9
ENSG00000289071	NA	2.95154482696379	0.031923108381598	M1_vs_M2	NA	NA	NA	NA	NA	CD46	ACRBP
ENSG00000289080	NA	-2.03024518212246	9.41426790511099e-4	M1_vs_M2	HSALNG0110565	integenic	Not conserved	hsa-miR-1228-5p,hsa-miR-4492	Lymphocyte count,-	RABEP2	SNX32
ENSG00000289092	NA	2.09633369702579	2.59229633873002e-9	M1_vs_M2	HSALNG0077924	anti_sense	Not conserved	hsa-miR-1273h-5p	Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration; Erythrocyte count	TIMM23	MAMDC4
ENSG00000289100	NA	2.90995073910695	7.984547330453511e-9	M1_vs_M2	HSALNG0049520	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7846-3p	NA	PFDN6	RN7SL368P
ENSG00000289127	NA	-4.81200907284228	6.34789121066542e-8	M1_vs_M2	HSALNG0137342	integenic	Q90	NA	NA	MID1IP1	DDX59
ENSG00000289161	NA	1.36092830220393	5.78365698890394e-13	M1_vs_M2	HSALNG0069294	anti_sense	Not conserved	hsa-miR-619-5p	-	MROH6	PER3
ENSG00000289173	NA	5.70759269860633	0.00242600005738758	M1_vs_M2	HSALNG0092178	integenic	Not conserved	hsa-miR-619-5p	-	CPM	OSR2
ENSG00000289197	NA	4.73450443277404	0.0482961318857051	M1_vs_M2	HSALNG0039059	integenic	Not conserved	NA	Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	HELT	LGALS14
ENSG00000289198	NA	1.99538255779326	6.48900687429194e-5	M1_vs_M2	HSALNG0052920	integenic	Q90	NA	-	MARCKS	QRSL1
ENSG00000289298	NA	-1.48272583607739	1.67296283026484e-4	M1_vs_M2	HSALNG0126206	integenic	Not conserved	NA	NA	CEACAM4	ENSG00000279433
ENSG00000289331	NA	4.89857018749063	0.0421938901589093	M1_vs_M2	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6	BLACAT1
ENSG00000289351	NA	-2.39956466196895	1.30689077754554e-4	M1_vs_M2	HSALNG0028867	integenic	Not conserved	NA	NA	COPG1	ENSG00000229337
ENSG00000289365	NA	3.24674075425499	1.08940112298816e-6	M1_vs_M2	HSALNG0139497	integenic	Q50	NA	NA	NXT2	KCNE5
ENSG00000289372	NA	5.30013871557365	0.0171686460290411	M1_vs_M2	HSALNG0053067	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4652-5p,hsa-miR-4710,hsa-miR-6089	Pulse pressure measurement,Systolic blood pressure,-	GOPC	PLEKHS1
ENSG00000289530	NA	5.41308534654347	0.0112654552754594	M1_vs_M2	HSALNG0035158	integenic	Q50	NA	-	RASSF6	ENSG00000289530
ENSG00000289548	NA	-5.98175992042232	2.54046921010475e-4	M1_vs_M2	HSALNG0146881	integenic	Not conserved	hsa-miR-762,hsa-miR-6803-5p,hsa-miR-6859-3p	NA	SLCO4A1	ATP5F1BP1
ENSG00000289564	NA	-2.87345771654841	0.0109324617153264	M1_vs_M2	HSALNG0134258	anti_sense	Not conserved	hsa-miR-619-5p	NA	PPIL2	MLXIP
ENSG00000289582	NA	5.14213858069723	4.60445340626244e-30	M1_vs_M2	NA	NA	NA	NA	NA	GBP2	ENSG00000291086
ENSG00000289587	NA	-3.37448776903845	0.0130133343922305	M1_vs_M2	HSALNG0118245	anti_sense	Q50	NA	Post-traumatic stress disorder	APOH	MAML2
ENSG00000289589	NA	6.28288199891844	6.67848247821552e-5	M1_vs_M2	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6	CARMIL3
ENSG00000289618	NA	-2.35485611690793	0.0201891740361232	M1_vs_M2	HSALNG0112251	anti_sense,sense	Not conserved	NA	Eosinophil count,High density lipoprotein cholesterol measurement,-	DUS2	NR1D1
ENSG00000289691	NA	1.02330202265001	0.0496650249462026	M1_vs_M2	HSALNG0060000	sense	Q75	hsa-miR-619-5p	-	PILRA	ENSG00000259762
ENSG00000289725	NA	-3.24682922371906	8.95521107626534e-4	M1_vs_M2	HSALNG0071598	integenic	Not conserved	NA	NA	ZNG1E	ERMN
ENSG00000289844	NA	5.300632195056	0.0145127671261417	M1_vs_M2	HSALNG0102515	integenic	Q75	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-6089,hsa-miR-6769a-3p	Periodontitis,Basophil count; Basophil percentage of leukocytes,Total blood protein measurement,-	FOS	LPAR4
ENSG00000289880	NA	3.96901213493146	2.47174539309898e-10	M1_vs_M2	NA	NA	NA	NA	NA	FAM177B	TRBV5-4
ENSG00000289881	NA	-3.18853058893456	0.0295429836698496	M1_vs_M2	HSALNG0004816	integenic	Not conserved	hsa-miR-4534,hsa-miR-5047,hsa-miR-6830-5p	Survival time; Lung carcinoma,-	SSX2IP	ENSG00000289881
ENSG00000289942	NA	5.17910788280794	0.0117843134130913	M1_vs_M2	NA	NA	NA	NA	NA	TMPRSS11E	SLC8A3
ENSG00000289947	NA	3.12471298170762	0.0200887099605636	M1_vs_M2	NA	NA	NA	NA	NA	ODF3B	WWC3
ENSG00000289958	NA	-4.78860402710027	0.020509993853045302	M1_vs_M2	HSALNG0048244	integenic	Not conserved	NA	-	MCUR1	PHF13
ENSG00000289977	NA	-3.08996436363374	1.30875824917608e-6	M1_vs_M2	HSALNG0114255	integenic	Not conserved	NA	NA	ACADVL	LTA4H
ENSG00000290034	NA	-1.17384512081198	0.00163038735897479	M1_vs_M2	HSALNG0049994	anti_sense	Q50	hsa-miR-6728-3p,hsa-miR-8485	C-reactive protein measurement,Isoleucine measurement; Leucine measurement,Supraventricular ectopy,Family history of alzheimer’s disease; Late-onset alzheimers disease,Late-onset alzheimers disease,Aortic stenosis; Aortic valve calcification,-	TREML4	ENSG00000274508
ENSG00000290041	NA	1.91397444405026	7.11303509879663e-13	M1_vs_M2	HSALNG0003215	anti_sense,sense	Q75	hsa-miR-619-5p	Soluble triggering receptor expressed on myeloid cells 2 measurement,Intraocular pressure measurement,-	BTBD19	WAKMAR2
ENSG00000290054	NA	-5.61529345902824	3.85270511703446e-4	M1_vs_M2	HSALNG0031957	sense	Not conserved	NA	NA	PIGX	WBP1L
ENSG00000290095	NA	-2.99562033073165	0.0081671815139171	M1_vs_M2	NA	NA	NA	NA	NA	GALNTL5	IGSF3
ENSG00000290385	NA	2.26254481065698	0.00577781717984302	M1_vs_M2	HSALNG0000017	integenic	Not conserved	NA	NA	OR4F29	GCC1
ENSG00000290394	NA	2.55215735983915	0.0143108070318268	M1_vs_M2	HSALNG0109791	anti_sense	Not conserved	hsa-miR-6837-5p	-	RRN3	PPP1R1A
ENSG00000290399	NA	3.60500292304799	5.70684426670055e-6	M1_vs_M2	HSALNG0104477	integenic	Not conserved	NA	NA	NIPA1	C22orf42
ENSG00000290418	TPTEP1	-1.29566042416843	1.5652522837449e-14	M1_vs_M2	HSALNG0133819	integenic	Not conserved	NA	-	IL17RA	ECH1
ENSG00000290427	NA	-1.55572886558187	1.55639072634166e-21	M1_vs_M2	HSALNG0123614	integenic	Not conserved	NA	Susceptibility to chronic sinus infection measurement	MBD3L2B	HS2ST1
ENSG00000290441	NA	5.70674227392156	0.00229240090212765	M1_vs_M2	HSALNG0148215	integenic	Not conserved	hsa-miR-4505,hsa-miR-1587	NA	TLR2	PLCB4
ENSG00000290525	GBP1P1	7.25250769955078	1.07352393505668e-51	M1_vs_M2	NA	NA	NA	NA	NA	GBP6	OR2I1P
ENSG00000290644	NA	-2.72320038800531	0.0220015212850711	M1_vs_M2	HSALNG0072753	integenic	Not conserved	hsa-miR-3178,hsa-miR-4505,hsa-miR-6514-3p	-	CENPP	C14orf119
ENSG00000290710	HLA-V	2.67044851351831	5.57400258781275e-5	M1_vs_M2	NA	NA	NA	NA	NA	HLA-G	HLA-A
ENSG00000290718	FAM95B1	-3.15867593290728	5.22775459304293e-4	M1_vs_M2	HSALNG0071261	integenic	Not conserved	NA	-	SPATA31A1	IGLV2-11
ENSG00000290727	ALMS1P1	5.9502938870326	6.27984781041797e-4	M1_vs_M2	HSALNG0015975	anti_sense	Not conserved	NA	Serum metabolite measurement; Urinary metabolite measurement,-	ALMS1	CBX4
ENSG00000290735	NA	4.03551842741343	1.13742295361961e-4	M1_vs_M2	HSALNG0006949	integenic	Not conserved	NA	NA	H3-7	GPC5
ENSG00000290838	NCF1B	7.36015708501299	1.8074539214086601e-9	M1_vs_M2	HSALNG0058823	integenic	Not conserved	hsa-miR-619-5p	NA	FKBP6	MT1E
ENSG00000290858	NA	6.34063500798682	7.34871194095677e-5	M1_vs_M2	HSALNG0115677	integenic	Q90	hsa-miR-4478,hsa-miR-6089	Protein measurement,-	TEFM	MMP10
ENSG00000290866	OTOAP1	-3.71387047431273	4.9666176508859005e-22	M1_vs_M2	NA	NA	NA	NA	NA	NPIPB5	MZT2A
ENSG00000290867	LINC01145	1.79455134913971	1.95163206017105e-5	M1_vs_M2	HSALNG0142314	integenic	Not conserved	NA	-	PPIAL4D	RELA-DT
ENSG00000290873	LINC03009	1.74669830085862	1.79977188635437e-5	M1_vs_M2	NA	NA	NA	NA	NA	UPK3B	ENSG00000265798
ENSG00000290927	NA	2.09434724728291	2.36646820323766e-34	M1_vs_M2	HSALNG0110892	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-320a-5p,hsa-miR-4289,hsa-miR-6132,hsa-miR-6722-3p,hsa-miR-6776-5p	-	KRBOX5	DNM3
ENSG00000290928	NA	-1.16016676427652	0.00388326217473319	M1_vs_M2	HSALNG0115658	integenic	Not conserved	NA	NA	ATAD5	F12
ENSG00000290999	NA	3.36080055844812	4.00447695052348e-5	M1_vs_M2	NA	NA	NA	NA	NA	SEC22B	IL36RN
ENSG00000291005	NBPF25P	-1.91700725512075	7.25976208595098e-5	M1_vs_M2	HSALNG0006737	anti_sense	Not conserved	NA	Breast carcinoma,-	PDZK1	DCTN3
ENSG00000291006	NA	1.56889355710961	2.37730791141651e-10	M1_vs_M2	NA	NA	NA	NA	NA	TMEM14A	FSD1L
ENSG00000291040	CD99P1	-2.92565427315372	6.23293938015968e-23	M1_vs_M2	HSALNG0136380	integenic	Not conserved	NA	Adolescent idiopathic scoliosis	CD99	IFT80
ENSG00000291049	FAM86B3P	-1.20488693279403	1.67751630567656e-4	M1_vs_M2	NA	NA	NA	NA	NA	ZNF705B	RPS18
ENSG00000291086	LGALS17A	5.96344171720489	8.050364302793409e-22	M1_vs_M2	HSALNG0126029	integenic	Not conserved	NA	NA	LGALS14	ENSG00000289582
ENSG00000291091	SDHAP4	-1.24406789261633	1.05301177195644e-34	M1_vs_M2	HSALNG0032044	integenic	Not conserved	hsa-miR-4281	NA	BDH1	TBXAS1
ENSG00000291097	HLA-L	1.69516606474401	1.7905634889292198e-16	M1_vs_M2	HSALNG0049134	integenic	Not conserved	NA	NA	TRIM39	H4C8
ENSG00000291104	BTN2A3P	1.21048304043287	4.52220915163821e-5	M1_vs_M2	HSALNG0048771	integenic	Not conserved	NA	NA	BTN3A1	MKLN1
ENSG00000291114	SIGLEC17P	-1.67153187104276	1.0735796684816901e-15	M1_vs_M2	NA	NA	NA	NA	NA	SIGLEC7	ZNF551
ENSG00000291135	FCGR1BP	3.56425464837246	4.20628157063743e-13	M1_vs_M2	NA	NA	NA	NA	NA	SRGAP2C	LINC02541
ENSG00000291143	NA	2.31602451951209	1.8794284889711e-19	M1_vs_M2	NA	NA	NA	NA	NA	OR2AG2	TLK2
ENSG00000291155	CT75	5.11314595411629	3.84759608912761e-11	M1_vs_M2	HSALNG0022522	integenic	Q50	hsa-miR-4308,hsa-miR-4467,hsa-miR-3960	Susceptibility to scarlet fever measurement,-	SGPP2	MT1E
ENSG00000291158	LINC00869	2.18185498286542	5.79300249999864e-7	M1_vs_M2	HSALNG0141914	integenic	Not conserved	NA	NA	PPIAL4C	AK9
ENSG00000291173	CASP4LP	3.06559737128339	1.37390094906574e-5	M1_vs_M2	NA	NA	NA	NA	NA	CASP12	COPS2
ENSG00000291174	NA	1.76091094033132	7.72795654005771e-4	M1_vs_M2	NA	NA	NA	NA	NA	FRMD8	LIN52
ENSG00000291178	NA	1.32158815756455	0.0373211569123875	M1_vs_M2	HSALNG0059995	anti_sense	Not conserved	hsa-miR-619-5p	Hemoglobin measurement,Family history of alzheimer’s disease; Late-onset alzheimers disease; Red blood cell distribution width,Platelet count; Platelet crit,-	ZCWPW1	NCALD
ENSG00000291186	NA	-1.27016811301865	7.89664013750077e-4	M1_vs_M2	NA	NA	NA	NA	NA	DEFB108B	ENSG00000289470
ENSG00000291223	FAM86DP	-1.49749702713878	1.10559747121011e-11	M1_vs_M2	HSALNG0026916	integenic	Not conserved	hsa-miR-485-5p	NA	ZNF717	RBBP7
ENSG00000291224	NA	-1.14375736072178	0.0121515875475312	M1_vs_M2	HSALNG0024079	anti_sense	Not conserved	hsa-miR-6736-3p	Blood protein measurement,Body weight,3-hydroxypropylmercapturic acid measurement,-	FANCD2	WWOX
ENSG00000291233	NA	1.31158576883423	0.0476795441462751	M1_vs_M2	NA	NA	NA	NA	NA	NBPF9	TAF13
ENSG00000291236	NA	3.29128545357905	0.00663016755730955	M1_vs_M2	NA	NA	NA	NA	NA	TNS1	FAM107A
ENSG00000291258	NA	3.21162812965388	0.00845343825818688	M1_vs_M2	HSALNG0144341	overlap_antisense	Not conserved	hsa-miR-363-5p,hsa-miR-6089	-	APBA2	UTP25
